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ABSTRACT 
 
 
 
Ovarian hyperstimulation is achieved through ovarian gonadotropin 
stimulation, and thus associated with supraphysiological levels of 
oestrogen and progesterone. To investigate the effects of exogenous 
gonadotropins on the expression of TGF β1 and TGF β2, which have 
been recognized as possible modulators of many endometrial 
functions, FSH and hCG were superimposed upon the normal hormonal 
milieu of the cycling rat, prior to mating. Endometrial tissue was 
collected at 4.5, 5.5 and 6.5 days after mating. ELISA was performed 
to estimate blood oestrogen and progesterone levels and 
immunohistochemistry was undertaken to localize TGF β1 and TGF β2 in 
the uterine endometrium. Apart from the known detrimental effects of 
hyperstimulation on gross morphology, hormone levels and 
endometrial histology, the hyperstimulation was also found to affect 
TGF β expression. An increase in the expression of TGF β2 was distinct 
in the glandular epithelium of the hyperstimulated animals, while 
regionalized expression of both TGF β1 and TGF β2 was prominent in 
the stroma. In conclusion, hyperstimulation affects the expression of 
both TGF β1 and TGF β2, which may contribute to the disruption of the 
endometrial environment required for successful embryo implantation. 
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1. INTRODUCTION 
 
 
Despite numerous innovations in assisted reproductive technologies 
(ART), implantation rates per human embryo transfer are still very low 
and rarely exceed 30% (Human Fertilization and Embryology 
Authority, 2006). The majority of these technologies utilize controlled 
ovarian superovulation (hyperstimulation) for oocyte collection before 
the replacement of the fertilized oocyte into the uterine tube or uterus. 
 
Hyperstimulation, the artificial induction of superovulation by the 
administration of follicle stimulating hormone (FSH) and human 
Chorionic Gonadotropin (hCG) is routinely used in ART 
(http://www.advancedfertility.com/ovarstim.htm). It has been shown 
that FSH and hCG cause adverse morphological and molecular changes 
in the endometrium (Stein and Kramer, 1989; Kramer et al., 1990; 
Kramer and de Wet, 1994; Peverini and Kramer, 1995). In addition, 
changes have also been noted in the implanting embryo (Ertzeid and 
Storeng, 2001; Terry et al., 2001), altering the conditions necessary 
for normal implantation. 
 
Administration of exogenous hormones is found to increase the 
amount of circulating oestradiol prior to implantation (Kramer, 1990), 
affect the progesterone: oestradiol ratio (Kramer et al., 1993, Kramer 
and de Wet, 1994), decrease the vascular permeability of the 
endometrium (Kramer, 1997), prevent decidualization of the 
subepithelial stromal cells (Stein and Kramer, 1989) and reduce 
carbohydrates in the glycocalyx of the endometrium (Kramer and de 
Wet, 1994; Peverini and Kramer, 1995). 
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Considering the effects of exogenous hormones on the endogenous 
hormonal milieu as well as the endometrial environment, and the low 
rate of implantation concomitant with these, it has been concluded 
that both gross and molecular factors play an essential role in priming 
the uterus for reception of the embryo.  
 
 
1.1. Hormonal control of endometrial function  
 
 
The human endometrium is the end organ for the signals derived from 
the hypothalamic-hypophysial-ovarian axis. It is thus subjected to 
changes that will occur if the normal functioning of this axis becomes 
disturbed. Endometrial cells in the rat and mouse are under tight 
control of the interaction between the ovarian steroid hormones, 
oestrogen and progesterone (Psychoyos, 1973; Tabibzadeh, 1998). In 
the adult non-pregnant mouse, oestrogen directs proliferation of 
uterine epithelial cells, while the same process in the stroma requires 
both oestrogen and progesterone. These hormones have similar effects 
in the pregnant uteri of mice. On days 1 and 2, pre-ovulatory ovarian 
oestrogen stimulates cell proliferation. On day 3, progesterone, from 
corpora lutea, induces stromal cell proliferation, which is further 
potentiated on day 4 by ovarian oestrogen secretion. On the same 
day, epithelial cells stop proliferating and become differentiated, which 
makes the uterine epithelium receptive to the blastocyst (Carson et 
al., 2000; Dey et al., 2004).  
 
3 
Furthermore, Yoshinaga et al. (1969) showed results of oestrogen 
secretion during the oestrous cycle and early pregnancy in the rat, by 
using an intravaginal bioassay. According to their observations, 
oestrogen expressed a 24-hr secretion periodicity during the pre-
implantation period. They registered measurable oestrogen levels in 
the rat ovarian venous plasma only at noon of each day of the normal 
cycle. Oestrogen further showed a continuous rise on the day before 
pro-oestrus and including pro-oestrus, with its maximum at noon of 
pro-oestrus. However, in early pregnancy, a continuous rise of this 
hormone was absent, while daily rhythmicity persisted. At noon of day 
4 of pregnancy, oestrogen levels reached their maximum.  
 
In addition, results obtained using an ovariectomy procedure at 
different times during  early pregnancy have shown that ovariectomy 
followed by  progesterone treatment from day 4 of  pregnancy in the 
rat can be performed without disturbing the events of normal 
implantation. Animals ovariectomized earlier, showed delayed 
implantation until oestrogen was added to the progesterone treatment 
(Psychoyos, 1973). Moreover, hypophysectomy performed on the 
afternoon of day 3 of pregnancy, blocked implantation in 
progesterone-treated rats. If this procedure was carried out on the 
afternoon of day 4, progesterone treatment alone was sufficient to 
allow normal and timely implantation (Psychoyos, 1973).  
 
It may be concluded from the above, that events that take place 
during the pre-implantation and peri-implantation period are 
hormonally influenced. Any procedure that will temporarily or 
permanently interfere with normal hormonal functioning of the 
4 
hypothalamic-hypophysial-ovarian axis will interfere with normal 
implantation.   
 
 
1.2. The molecular basis for embryo implantation 
 
 
Endometrial receptivity is a transitory and unique stage during which 
the endometrial cells achieve their maximum growth and sensitivity to 
the blastocyst. This window of implantation or receptive phase has a 
limited time and lasts less than 24 hours in rodents, after which the 
uterus becomes refractory for embryo implantation (Psychoyos, 1986; 
Aplin, 1997; Adams et al., 2004). 
  
The events that take place during the receptive or peri-implantation 
period require precise synchronization between ovarian oestrogen and 
progesterone. In mice and rats, oestrogen is essential for preparation 
of the progesterone-primed uterus for the receptive state, when the 
uterine milieu becomes favorable to blastocyst acceptance and 
implantation (Psychoyos, 1973). This delicate coordination involves the 
synchronized production of corresponding molecules that bind the 
apical uterine epithelium and the implanting trophectoderm surface. 
This results in the attachment of two opposing membranes, which is 
the initial and necessary event that will consequently result in 
successful implantation (Carson et al., 2000). 
 
Some cases of unexplained infertility may be due to disrupted 
endometrial function, which may originate from alterations in the 
molecular repertoire that are crucial for implantation. The molecular 
5 
members that make the endometrium receptive to implantation are 
gradually being recognized. Among these are cytokines, such as 
leukemia inhibitory factor (LIF). According to Bhatt et al. (1991), LIF is 
expressed on day four of pregnancy, the day of commencement of 
implantation in the mouse. Growth factors such as heparin binding 
epidermal growth factor (Lim et al., 2006), are proposed to be 
important  during implantation, by accelerating the expression of ανβ3 
integrin in the peri-implantation mouse uterus. Das et al. (1995) 
showed that amphiregulin, a progesterone-regulated uterine epithelial 
cell growth factor, is associated with epithelial cell differentiation 
during implantation.  Das et al. (1997a) have also established that the 
expression of beta-cellulin and epiregulin are restricted to the mouse 
uterine luminal epithelium and underlying stroma adjacent to the 
implanting blastocyst. Moreover, glycoconjugates such us 
proteoglycans including heparan sulfate are also required for 
implantation-related processes and participate in the early stages of 
embryo attachment (Farach et al., 1987; 1988).  
 
Tabibzadeh et al. (1996) emphasized that the function of heat shock 
proteins may be to protect cells against the cytotoxic damage of TNF-
alpha, particularly during the critical period of the “window of 
implantation”. In addition, Fukuda et al. (1995) highlighted the role of 
the tastin-trophinin adhesion molecule complex which has a function in 
embryo implantation. Suzuki et al. (1998) subsequently established 
that bystin, a cytoplasmic protein, interacts with trophinin, tastin and 
cytokertain to promote cell adhesion between trophoblast and 
endometrial cells.  
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Additional markers of endometrial receptivity are matrix 
metalloproteases (MMPs) and their inhibitors - tissue inhibitors of 
metalloproteinases (TIMPs). By inhibiting MMPs activities, TIMP’s 
participate in alteration of the extracellular matrix and thus have a role 
in decidual tissue remodeling and regulation of trophoblast invasion 
(Fisher and Damsky, 1993; Alexander et al., 1996). Another molecular 
member of the receptive endometrium is COX-2 (cyclooxigenase-2), 
an enzyme that is responsible for formation of important biological 
mediators such as prostaglandins. Cox-2 deficient females have 
multiple reproductive failures that include defects in ovulation, 
fertilization and implantation (Lim et al., 1997). Integrins have also 
been found to be expressed during the “window of implantation” in 
both human and mice (Tabibzadeh, 1998). They represent the cell 
surface receptors that interact with the extracellular matrix and 
mediate various intracellular signals.  αVβ3 integrin is expressed 
during the window of implantation, but is absent in certain types of 
infertility, including the luteal phase defect (Lessey et al., 1992). 
 
 
1.3. Transforming growth factor β  (TGF β) 
 
The transforming growth factor βs (TGF βs) belong to a superfamily 
known as the transforming growth factor β superfamily. Apart from 
TGF βs, this family includes inhibins, activin, anti-mullerian hormone, 
bone morphogenic protein, decapentaplegic and Vg-1. TGF βs are 
structurally related dimeric, disulfide linked peptide hormones. 
Members of this family include five TGF β isoforms (TGF β1-5) of which 
three isoforms (TGF β 1, TGF β 2 and TGF β 3) are prevalent in 
mammals.  
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The peptide structures of the three proteins are similar. They are all 
synthesized as prepropeptides of 112-114 amino acids that dimerize to 
give rise to active growth factors (Das et al., 1992). TGF β dimer binds 
to specific receptors on the cell surface. Although four receptors have 
been cloned (type I, II, III and endoglin), only type I and II receptors 
have been proven to mediate TGF β signaling. They are both serine-
threonine kinases that signal through the Smad family of proteins 
(Lawrence, 1996). Binding of TGF β to its cell surface receptor Type II 
leads to the phosphorylation of the Type I receptor. The Type I 
receptor is then able to phosphorylate and activate the Smad 2 
protein, an intracellular transducer of the TGF β  superfamily. The 
Smad 2 and Smad 4 complex enters the cell nucleus and becomes 
involved in recruiting other transcription factors. Through these actions 
TGF β control expression of target genes that mediate biological effects 
of these growth factors (Kawabata et al., 1999; Lin et al., 2006). 
 
TGF βs are multifunctional growth factors that regulate many aspects 
of cellular activities including cell growth, proliferation and 
differentiation, tissue remodeling, extracellular matrix formation, 
control of cell surface molecules, immunoregulation, angiogenesis and 
apoptosis. Potential roles of TGF βs have been identified in gonad and 
secondary sex organ development, spermatogenesis and ovarian 
function, immunoregulation of pregnancy, embryo implantation and 
placental development (Ingman and Robertson, 2002). 
 
TGF β isoforms express overlapping in their functions but they also 
have unique actions within the cell. For example, TGF β1 was identified 
in human platelets as a protein with a potential role in wound healing 
(Assoian et al., 1983). TGF β1 was found to be secreted by most 
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leukocytes (Letterio and Roberts, 1998).  Some T cells release TGF β1 
to inhibit the actions of other T cells. Interleukin 1 and interleukin 2-
dependant proliferation of activated T cells is prevented by the activity 
of TGF β1 (Gilbert et al., 1997; Wahl et al., 2006). Similarly, TGF β1 can 
inhibit the secretion and activity of many other cytokines such as 
interferon-γ, tumor necrosis factor-alpha (TNF-α)  and various 
interleukins. It can also increase the expression levels of cytokine 
receptors, such as IL-2 receptor to down-regulate the activity of 
immune cells. However, TGF β1 can also increase the expression of 
several cytokines in T cells and promote their proliferation, particularly 
in immature cells (Lettario and Roberts, 1998). In addition, TGF β1 
inhibits proliferation and apoptosis of B cells and plays a role in 
controlling the expression of antibodies on the immature and mature B 
cells (Lebman and Edmiston, 1999). The effects of TGF β1 on 
macrophages and monocytes are predominantly deactivating, but 
according to Bogdan and Nathan (1993) they can have macrophage-
activating effects as well. 
 
TGF β2 has a vital role during embryonic development (Pelton et al., 
1991) but is also known to suppresses the effect of interleukin 
dependant T-cell tumors 
 
Since embryo-uterine interactions during the process of implantation 
involve each of these processes, it seems that these growth factors 
may play an important role during the peri-implantation period (Das et 
al., 1992). 
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1.4. TGF βs   and implantation  
 
 
The endometrium represents a highly specialized uterine tissue which 
provides an optimal environment for implantation of the semi-allogenic 
embryo (Jones et al., 2006). Being an end organ for the signals 
derived from the hypothalamic-pituitary-ovarian axis, the 
uterus/endometrium is under the control of the ovarian steroids, 
oestrogen and progesterone. Following oestrogen-induced cell 
proliferation, progesterone promotes cell differentiation within the 
endometrium, establishing an environment receptive for embryo 
implantation (Salamonsen and Jones, 2003).  
 
Studies have shown that apoptosis is increased in the rat endometrium 
during implantation and during regression of the decidua basalis 
(Abrahamsohn and Zorn, 1993; Pampfer and Donnay, 1999). mRNA 
for TGF β1 has been shown to be present within the uterus during 
pregnancy in the rat and was localized to the luminal and glandular 
epithelial cells during early and late pregnancy (Chen et al., 1993). 
TGF β1 and TGF β2 mRNAs were also found in the mouse uterus in the 
luminal and glandular epithelia on days 1-4 of pregnancy, and in the 
extracellular matrix of the stroma and decidual cells (Tamada et al., 
1990; Lea et al., 1992).  TGF β2 and TGF β3 mRNAs were shown to be 
expressed in the uterus of the mouse in the peri-implantation period. 
TGF β2 was found in the luminal and glandular epithelia, the 
myometrium and decidua, while TGF β3 was mostly localized to the 
myometrium (Das et al., 1992). 
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Shooner et al. (2005) demonstrated an increase in TGF β1 and TGF β2 
expression on days 5.5 and 6.5 in the rat, whereas TGF β3 protein was 
not detected on these days of early pregnancy. Immunohistochemical 
analyses revealed that TGF β1 and TGF β2 were found surrounding the 
epithelium (luminal and glandular) in the stromal compartment at the 
implantation site, while TGF β3 was present at the time of decidua 
basalis regression in late pregnancy of the rat (Shooner et al., 2005). 
 
 
 
 
 
1.5. AIM OF STUDY 
 
The aim of this investigation is to determine if the administration of 
exogenous gonadotropins, FSH (follicle stimulating hormone) and hCG 
(human chorionic gonadotropin), which has a luteinizing effect (and 
which together cause hyperstimulation and therefore superovulation), 
adversely affect the expression of TGF β1 and TGF β2 in the rat uterus 
during the peri-implantation period. Differences in the normal 
expression of these growth factors in the endometrium/embryo 
following hyperstimulation, may indicate the requirement for 
transforming growth factors in successful embryonic implantation. 
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2. MATERIALS AND METHODS 
 
 
Clearance for this experiment was obtained from the Animal Ethics 
Committee, University of the Witwatersrand (clearance no 
2004/100/4). 
 
Thirty six adult, virgin, female Spraque-Dawley rats weighing between 
200 – 250g and two male rats of proven fertility were housed in the 
animal unit of the University of the Witwatersrand. The animals had 
free access to food and water and were maintained at a constant 
temperature of 22° C. A regular 12h day and 12h night cycle was also 
maintained.  
 
Vaginal smears of the female rats were taken daily until a regular 4- 
day oestrus cycle had been established. The daily smears were fixed in 
alcohol and stained using Shore’s technique (Drury and Wallington, 
1980) (Appendix 1). The stages of the oestrus cycle were assessed 
according to Kent and Smith (1945) (Appendix 2). The phases of the 
oestrus cycle are: oestrus, metoestrus, dieostrus (early, mid and late) 
and pro-oestrus. Only those animals showing at least three 
consecutive regular 4-day cycles were used in the study. 
 
The 36 female rats were divided into six groups of six animals each. 
Three groups (n=18) represented the control animals and the 
remaining three, the experimental groups (n=18), which underwent 
hyperstimulation. After mating and establishing of the vaginal plugs or 
spermatozoa in the vaginal smears, animals from both experimental 
12 
(hyperstimulated) and control groups were further divided into groups 
of six animals each. Each group represented a different stage of 
pregnancy namely 4.5, 5.5 and 6.5 days (see flow diagram). 
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2.1. Experimental Group (n=18) 
 
Each animal received an intraperitoneal injection of 20 i.u. of FSH 
(Folligon, Intervet, JHB) at mid-day of mid-dioestrus followed by an 
intraperitoneal injection of 20 i.u. of hCG (Chorulon, Intervet, JHB) 
24h later i.e. at mid-day of  late dieostrus (Kramer et al., 1993). Since 
it has been shown that the endometrial changes in the human female 
and in the rat are very similar at the time of implantation (Psychoyos 
and Martel, 1985), female rats in the present study have been 
hyperstimulated in phase with the oestrus cycle to simulate the 
conditions comparable to human IVF.  Hyperstimulation results in the 
increased secretion of the ovarian hormones and the subsequent 
increase in production of oocytes (superovulation). 
 
2.2. Control Group (n=18) 
 
Each control animal received an intraperitoneal injection of 0.1ml of 
sterile saline at mid-day of mid-dioestrus followed by an 
intraperitoneal injection of 0.3ml of sterile saline 24h later i.e. at mid-
day of late dieostrus. The volumes of the sterile saline given to the 
control animals at mid-dioestrus and late dioestrus were the same as 
the volumes of exogenous gonadotropins that were administered to 
the hyperstimulated animals at the relevant time of the oestrus cycle. 
  
All animals from both the experimental and control groups were mated 
with proven fertile males on the evening of the day when they 
received the second injection i.e. when they were in pro-oestrus. The 
morning following mating was taken as day 0.5 of pregnancy. The 
presence of a mucous vaginal plug or spermatozoa in the vaginal 
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smears on the morning following mating indicated successful 
copulation. Vaginal smears were continued daily until the day of 
sacrifice, to confirm the maintenance of pregnancy. Pregnancy smears 
are predominantly leukocytic with an abundance of mucous secretion. 
Those animals still showing pregnancy smears on the day of sacrifice 
were used for further investigation. 
 
Animals in both the experimental and control groups were sacrificed on 
days 4.5, 5.5 and 6.5 of pregnancy (the peri-implantation period). 
Rats were anaesthetized with a mixture of 0.6ml Chanazen (Centaur 
Labs, Johannesburg, South Africa) and 0.24ml Ketamine (Centaur 
Labs, Johannesburg, South Africa). 
 
Heart punctures were performed and blood (5ml) from the ventricle of 
each animal was collected in sterile heparin tubes. The blood was 
immediately centrifuged. The plasma was stored at -70°C for an ELISA 
(enzyme-linked-immunosorbent assay), in order to estimate blood 
oestrogen and progesterone levels at the time of death. 
 
The pontamine blue technique was used to demonstrate implantation 
sites (Finn and Porter, 1975). The inferior vena cava was surgically 
exposed and a 1 % pontamine blue solution (0.5ml) was injected into 
the vessel and allowed to circulate for 10-15 minutes to localize the 
implantation sites. The uterine horns were removed. Implantation sites 
(blue bands) were dissected out and fixed for 24 hours in 10% neutral 
buffered formalin solution (Appendix 3). Tissues were then dehydrated 
through a graded series of alcohols, cleared in chloroform (Automatic 
Tissue Processor, Shandon Citadel 1000) and embedded in paraffin 
wax.  Tissues were maintained at room temperature until routine 
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histology and immunohistochemical localization of specific antigens 
were performed. 
 
Following removal of the implantation sites, the animals were killed by 
exsanguination. 
 
2.3. Progesterone and oestradiol ELISA 
 
An ELISA (enzyme linked-immunosorbent assay) was carried out to 
determine the plasma concentrations of oestradiol and progesterone 
by using an oestradiol (E2) enzyme immunoassay test kit and a 
progesterone enzyme immunoassay test kit (Linear Chemicals, Spain). 
The assay kits are based on the principle of competitive binding 
between unlabelled hormone in the test specimen (e.g. E2) and a fixed 
quantity of E2-HRP conjugate for a constant amount of rabbit anti- E2. 
For the incubation, goat anti-rabbit IgG-coated wells are incubated 
with 25µl of the E2 standards, controls ( negative control in which an 
unknown antigen is omitted and a positive control which uses a known 
antigen), animal samples (test sample containing E2), 100 µl 
oestradiol-HRP conjugated reagent and 50µl rabbit anti-oestradiol at 
room temperature for 90 minutes. During incubation, a fixed amount 
of HRP-labelled E2 competes with endogenous E2 in the standard, 
sample or quality control serum for a fixed number of binding sites of 
the specific E2 antibody. Thus, the amount of E2 peroxidase conjugate 
immunologically bound to the well progressively decreases as the 
concentration of E2 in the specimen increases. 
 
Unbound E2 peroxidase conjugate was then removed and the wells 
washed with diluted wash solution (phosphate buffer pH 7.4, NaCl and 
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0.05% Tween 20). Next, a solution of 3,3 ,5,5 -tetramethylbenzidine 
(TMB) reagent is added and incubated at room temperature for 20 
minutes, resulting in the development of a blue color. The color 
development is stopped with the addition of 1N HCL, and the 
absorbance is measured spectrophotometrically at 450nm. The 
intensity of the color formed is proportional to the amount of enzyme 
present and is inversely related to the amount of unlabeled E2 in the 
sample. A standard curve was obtained by plotting the concentration 
of the standard versus the absorbance. The E2 concentration of the 
specimens and the controls were run concurrently with standards and 
were calculated from the standard curve. 
 
2.4. Statistics 
 
The unpaired Student “t”-test as well as the non-parametric Mann-
Whitney test was used for the statistical analysis of the plasma 
concentrations for progesterone and oestradiol and comparisons 
between the control and hyperstimulated animal groups. 
 
2.5. Histology 
 
Paraffin wax embedded uteri were cut at 4 µm and the sections were 
placed on glass slides coated with silane (Appendix 4). Sections were 
deparaffinised in xylene, rehydrated in a series of graded alcohols and 
then stained with haematoxylin and eosin (Appendix 5) in order to 
establish the morphology of the uteri at different stages of pregnancy. 
The haematoxylin and eosin staining method demonstrates a variety of 
different tissue structures (Bancroft and Gamble, 2002). The 
haematoxyln component stains nuclei blue-black (basophilic), while 
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the eosin stains the cell cytoplasm and connective tissue fibres in 
different shades of pink and red (eosinophilic) (Bancroft and Gamble, 
2002). 
 
2.6. Immunohistochemical staining 
 
Uterine tissue sections 4µm thick were mounted on silane-coated 
slides (Appendix 4). The sections were deparaffinized, rehydrated and 
then heated for 2x5 minutes in 10mM citrate buffer pH 6 (Appendix 6) 
containing Triton X-100 (Sigma Aldrich) 0.1% (v/v). Sections were 
washed in running water and Tris buffered saline  pH 7.6 (Appendix 7) 
containing Triton x-100 and then incubated with 0.3% hydrogen 
peroxide in distilled water for 30 minutes to quench endogenous 
peroxidase activity. After washing in running tap water and Tris 
buffered saline (TBS) for 5 minutes each, the sections were incubated 
with normal blocking serum (Vectastain Elite ABC Kit, Vector 
Laboratories, CA, USA) at room temperature for 1 hour. Then, the 
primary antibody diluted in TBS (TGF beta-1 or TGF beta-2; 1:100 
dilution, Santa Cruz Biotechnology, CA, USA) was added to the 
sections and incubated at 4°C overnight in a humidified chamber. After 
washing for 3x5 minutes in TBS containing Triton X-100, sections were 
incubated for 30 minutes with biotinylated secondary antibody (anti-
rabbit, Vectastain Elite ABC Kit, Vector Laboratories, CA, USA). 
Subsequently, sections were washed with TBS for 3x5 minutes and 
incubated with an avidin-biotin complex reagent containing 
horseradish peroxidase for 30 minutes. Sections were then washed 
with TBS for 3x5 minutes and colour development was achieved by 
applying the diaminobenzidine (DAB) substrate (Appendix 8) for 5 
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minutes. Sections were than washed in running water for 5 minutes, 
counterstained with hematoxylin and mounted in entellan.  
 
Preparation of mouse ovarian tissue (for control purposes) for 
sectioning and staining was carried out using the same method that 
was used for rat uterine tissue. Clearance for this part of the study 
was obtained from Animal Ethics Committee, University of the 
Witwatersrand (clearance no 06/17/01). 
 
 2.7. Immunocytochemistry controls 
 
To establish the specificity of the immunolabelling, the following 
immunocytochemical controls were used. 
 
Negative controls were performed using the same protocol as above, 
but substituting either the primary or secondary antibody with TBS or 
normal rabbit serum (NRS). Negative controls were always carried out 
on the section adjacent to a section of uterine tissue which showed 
immunolocalization.  
 
For absorption controls, absorption of the primary antibody with the 
purified antigen was used to show specificity of the antibody. The 
highest antibody dilution at which a constantly positive result is 
achieved was determined first. The primary antibody (at the 
concentration determined by the aforementioned method) was pre-
absorbed with its own antigen (blocking peptide sc-146 P for TGF β1 
and sc-90 P for TGF β2, Santa Cruz Biotechnology), overnight at 4 °C. 
The amount of blocking peptide used was a twenty-five-fold excess (by 
weight) diluted in 500µl of TBS. We were advised by Santa Cruz 
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Biotechnology to increase the concentration of blocking peptide for the 
absorption control to 25x excess of peptide to antibody by weight, 
instead of 5x (which was the  dose recommended in the Santa Cruz 
Biotechnology support protocol). Sections adjacent to the sections 
showing  immunolocalization for TGF β1 and TGF β2 respectively , were 
then incubated with antibody-antigen complex overnight at 4 °C. 
 
 
To show that the technique in each immunohistochemical run was 
successful, positive controls for both TGF β1 and TGF β2 were 
performed. The positive control consisted of the immunolocalization of 
the antibodies in a sample of mouse ovary known to contain TGF β1 
and TGFβ2 (Santa Cruz Biotechnology datasheets for TGF β1 (V): sc-
146 and TGF β2 (V): sc-90). 
 
2.8. Photography and images 
 
Uterine tissue sections were analyzed by light microscopy with the 
Zeiss Axioscope microscope (Axioscope 2, MOT, Carl Zeiss, Germany). 
Suitable images were taken with the digital camera (Sony 3 CCD) 
which was attached to the Axioscope. 
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3. RESULTS 
 
3.1. General observation  
  
Post-mortem examination of the ovaries and uterine horns showed 
distinct gross morphological differences between the control and 
hyperstimulated animals. The ovaries of the control animals at 4.5, 5.5 
and 6.5 days of pregnancy appeared small and rounded (Fig. 1). The 
ovaries of the hyperstimulated animals obtained from the stages of 
pregnancy used in this study showed gross enlargement with 
numerous, large follicles (Fig. 2). When ovaries from the control 
groups were compared to the ovaries of the hyperstimulated groups, a 
marked increase in size of the ovaries and an increase in follicular 
numbers were observed in the hyperstimulated animals at all three 
stages of pregnancy.  
 
The uterine horns of the control animals at 5.5 and 6.5 days of 
pregnancy showed numerous implantation sites (8 to 15 per animal), 
which were expressed as blue bands following the pontamine blue 
technique (Fig. 1). Only one control animal at 4.5 days of pregnancy 
showed three implantation sites indicated by the pontamine blue 
technique. The uterine horns in the hyperstimulated animals at 4.5, 
5.5 and 6.5 days of pregnancy were noticeably dilated when compared 
to control animals at the same stages of pregnancy (Fig. 2). The 
majority of the experimental animals from all three stages of 
pregnancy did not show blue-stained implantation sites. However, two 
animals in the hyperstimulated group at 5.5 days of pregnancy showed 
one visible implantation site per animal. 
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3.2. ELISA 
3.2.1. Progesterone ELISA 
 
The summary of the statistical values for progesterone plasma 
concentrations obtained from both control and hyperstimulated 
animals at 4.5, 5.5 and 6.5 days of pregnancy is shown in Table 1 and 
Table 2 respectively. All values for progesterone plasma concentrations 
are given in ng/ml. 
 
The mean progesterone level for control animals (Table 1) showed a 
statistically non-significant increase between 4.5 and 5.5 days of 
pregnancy (p=0.054). This was followed by a statistically non 
significant decrease in progesterone level on day 6.5 of pregnancy 
(p=0.060). 
 
In the hyperstimulated animals (Table 2) the progesterone plasma 
concentrations showed a gradual increase from 4.5 days through 6.5 
days of pregnancy. The increase from 4.5 to 5.5 days of pregnancy 
was statistically not significant (p=0.104) as well as the increase 
between 5.5 and 6.5 days of pregnancy (p=0.978). 
 
When progesterone plasma concentrations in the control animals were 
compared to those in the hyperstimulated animal groups (Table 1 and 
2), higher concentrations of plasma progesterone were evident within 
the latter group. However, a significantly higher (p=0.006) 
progesterone level was found only at 6.5 days of pregnancy, when the 
control and hyperstimulated animals were compared (Fig. 3).  
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There was no significant difference when progesterone plasma 
concentrations were compared between the 4.5 day control and 
hyperstimulated animal groups (p=0.362) or between the 5.5 day 
control and hyperstimulated groups (p=0.213).  
 
Table 1: Summary of the statistical values for progesterone 
concentrations in the control animals 
 
Factor Hormone Days of 
Pregnancy 
Number 
of 
animals 
Mean SD Min Max 
Control Progesterone 4.5 6 22.52 6.03 11.92 28.90 
Control Progesterone 5.5 6 28.17 1.97 26.87 30.78 
Control Progesterone 6.5 6 23.49 5.03 16.10 31.35 
 
 
Table 2: Summary of the statistical values for progesterone 
concentrations in the hyperstimulated animals 
 
Factor Hormone Days of 
Pregnancy 
Number 
of 
animals 
Mean SD Min Max 
Hyper-
stimulated 
Progesterone 4.5 5 25.45 4.50 19.10 31.33 
Hyper-
stimulated 
Progesterone 5.5 6 32.96 7.71 24.30 44.30 
Hyper-
stimulated 
Progesterone 6.5 7 33.07 4.99 26.20 39.18 
 
All values of progesterone concentrations are expressed in ng/ml 
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3.2.2. Oestradiol ELISA 
 
The summary of the statistical values for oestrogen plasma 
concentrations obtained from both control and hyperstimulated 
animals at 4.5, 5.5 and 6.5 days of pregnancy is shown in Table 3 and 
Table 4 respectively.  
 
In the hyperstimulated group at 5.5 days of pregnancy, statistical 
analysis was carried out on four samples only. The result obtained 
from one of those animals was discarded since it was extremely 
different (66.60 pg/ml) to the values obtained from the other animals 
at the same stage of pregnancy. The analyses were done with and 
without the high value and it made no difference to the outcome of the 
experiment (personal communication with statistician). Variability may 
have been due to variations in the time at which this animal was killed 
with respect to the other animals in this group. The second sample 
discarded was highly haemolysed and thus not suitable for the test.  
 
In the control group (Table 3) the oestradiol levels did not show a  
significant increase from 4.5 to 5.5 days of pregnancy (p=0.816) while 
a non-significant increase in oestradiol plasma concentrations was 
observed between 5.5 days and 6.5 days of pregnancy (p=0.164). 
 
In the hyperstimulated group (Table 4) oestradiol plasma 
concentrations were not significantly higher at 5.5 days of pregnancy 
when compared to those at 4.5 days of pregnancy (p=0.632). 
However, a significant decrease in oestradiol plasma concentrations 
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was observed in  animals at 6.5 days of pregnancy when compared to 
those at 4.5 and 5.5 days of pregnancy (p=0.038). 
 
When oestradiol plasma concentrations in the control animals were 
compared to those in the hyperstimulated animal groups (Table 3 and 
4), higher concentrations of plasma oestradiol were obvious in the 
latter group at 4.5 and 5.5 days of pregnancy (Fig. 4). However, 
significantly lower oestradiol levels were found in the hyperstimulated 
group when compared to the control group at 6.5 days of pregnancy 
(p=0.039). Oestradiol plasma concentrations between the 4.5 day 
control and hyperstimulated animals were not significant (p=0.249). 
This, too, was the case at 5.5 days of pregnancy (p=0.117).  
 
 
 
Table 3: Summary of the statistical oestradiol concentrations in the 
control animals 
 
 
Factor Hormone Days of 
Pregnancy 
Number 
of 
animals 
Mean SD Min Max 
Control Oestradiol 4.5 5 21.29 11.23 12.45 40.80 
Control Oestradiol 5.5 6 22.70 8.37 12.12 32.90 
Control Oestradiol 6.5 6 32.52 13.64 19.52 51.91 
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Table 4: Summary of the statistical oestradiol concentrations in the 
hyperstimulated animals 
 
 
Factor Hormone Days of 
Pregnancy 
Number 
of 
animals 
Mean SD Min Max 
Hyper-
stimulated 
Oestradiol 4.5 6 28.46 8.15 19.50 41.10 
Hyper-
stimulated 
Oestradiol 5.5 4 30.68 3.95 26.12 35.64 
Hyper-
stimulated 
Oestradiol 6.5 6 17.88 6.44 12.95 29.87 
 
 
All values of oestradiol concentrations are expressed in pg/ml 
 
 
3.2.3. Progesterone - Oestradiol (P:E2) ratio 
 
The summary of the progesterone:oestradiol ratio in the control and 
hyperstimulated animals is given in Table 5 and Table 6 respectively.  
 
The P:E2 ratio was calculated by dividing the P value in nm/ml by the 
E2 value in nm/ml x 10-3. When comparing the P:E2 ratio between the 
control and hyperstimulated groups, a slight increase was observed 
between 4.5 and 5.5 days of pregnancy. However, at 6.5 days of 
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pregnancy the P:E2 ratio showed a marked decrease (i.e. oestrogen 
was dominant) in the control group. In the hyperstimulated group at 
6.5 days of pregnancy the opposite happened, as the dominance of 
progesterone was noticeable and was demonstrated by a marked 
increase in the P:E2 ratio (Figs. 5 and 6). 
 
 
Table 5: Summary of the ratio between progesterone and oestradiol 
in control animals 
 
Day and Factor Progesterone 
(ng/ml) 
Oestrogen 
(pg/ml) 
P:E2 ratio 
4.5 control 
 
22.52 21.29 1.058 
5.5 control 
 
28.17 22.70 1.241 
6.5 control 
 
23.49 32.52 0.722 
 
 
Table 6:  Summary of the ratio between progesterone and oestradiol 
in hyperstimulated animals 
 
 
Day and Factor Progesterone 
(ng/ml) 
Oestrogen 
(pg/ml) 
P:E2 ratio 
4.5 
hyperstimulated 
25.45 28.46 0.894 
5.5 
hyperstimulated 
32.96 30.67 1.074 
6.5 
hyperstimulated 
33.08 17.87 1.849 
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3.3. Histology 
 
 
Histological examination of the sections of uterine tissue of both 
control and hyperstimulated animals was carried out prior to 
immunohistochemical analysis. 
 
The outline of the uterine lumen in most control animals at 4.5 days 
of pregnancy was slightly wavy in appearance (Fig. 7).  The luminal 
epithelial cells of the 4.5 days control animals were simple columnar 
with round to oval, basophilic, centrally placed nuclei (Fig. 8). The 
apical region of the luminal epithelial cells showed distinct and 
numerous microvilli (Fig. 8). Vacuoles were observed in the base of 
the luminal epithelial cells (Figs. 8 and 9). Several stromal cells at the 
antimesometrial pole were round with distinct round nuclei, indicating 
that decidualization had begun (Fig. 9). However, the majority of the 
stromal cells appeared flat and fibroblastic and the stromal tissue 
remained compact (Fig. 8). An abundance of glands was observed in 
the stroma. Glandular epithelial cells were simple cuboidal with round, 
centrally placed nuclei. Vacuoles surrounded the nuclei of the glandular 
epithelial cells (Fig. 9). 
 
Distinct differences were observed between control and 
hyperstimulated animals at 4.5 days of pregnancy. The uterine 
lumen of the hyperstimulated animals was noticeably dilated and the 
epithelium was very folded (Fig. 10). Luminal epithelial cells were 
columnar with large, oval, basally placed nuclei and with an apically 
situated microvillus boarder (Fig. 11). Vacuoles were not evident in 
these epithelial cells. The majority of the subepithelial stromal cells 
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were flat and fibroblastic (Fig. 11). Numerous glands were present in 
the stroma. Glandular epithelial cells were simple cuboidal with large, 
basally placed nuclei. Vacuoles were not present in the glandular 
epithelial cells at 4.5 days of pregnancy in the hyperstimulated animals 
(Fig. 12). 
 
The gross morphological features of the uterine tissue from both 5.5 
and 6.5 day control animals were similar to those at 4.5 days of 
pregnancy. The general outline of the luminal surface of 5.5 day 
control tissue was smooth (Fig. 13). In sections which were taken 
close to the implantation site, the opposite uterine walls were closer to 
each other (Fig. 14) and the blastocyst was engaged in the process of 
adhesion to the uterus. The luminal epithelial cells of the implantation 
chamber appeared reduced in size and layered, so that there were few 
cells between the trophoblast and epithelial basal lamina. At some 
places the epithelial cells were detached from the basal lamina (Fig. 
15). The rest of the luminal epithelial cells were simple columnar with 
round to oval, centrally placed, basophilic nuclei. Microvilli were 
present at the apical surface. Some vacuoles were evident at the base 
of the luminal epithelial cells (Fig. 16). A decrease in the presence of 
vacuoles was observed when comparisons were carried out between 
the three stages of pregnancy. Vacuoles were abundant at 4.5 days, 
after which their number decreased towards 6.5 days of pregnancy 
(compare Figs. 8, 16 and 19). Additionally, a decline in the presence of 
vacuoles was observed at 5.5 day of pregnancy from the mesometrial 
side of the uterus to the  antimesometrial side, where the cells were 
squamous and did not contain vacuoles (Figs. 18 and 19). In the 
subepithelial region, decidualization of the previously flat, fibroblastic 
stromal cells was visible (Fig. 16). The decidual cells contained round 
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nuclei and scanty cytoplasm. “Spaces” were evident between the 
decidual cells in this region. Blood vessels were also observed in the 
subepithelial compartment (Fig. 16). Clusters of uterine glands were 
apparent. The glandular epithelium remained simple cuboidal, with 
centrally placed, round, basophilic nuclei (Fig. 17). Vacuoles were 
present in the cytoplasm of the glandular epithelial cells.  
 
Additional changes were seen when sections of control uterine tissue 
at 5.5 days of pregnancy were compared to that at 6.5 days of 
pregnancy. More extensive decidualization of the stromal cells was 
evident in the uterus of animals at 6.5 days of pregnancy. Several 
blood vessels were observed in the stroma (Fig. 19). A gradual change 
in the shape of the luminal epithelial cells from the mesometrial side to 
the antimesometrial side was noticeable (Figs 18 and 19).  
 
Sections of the hyperstimulated uterine tissue of animals at 5.5 and 
6.5 days of pregnancy showed a dilated uterine lumen with extensive 
mucosal folds (Fig 20). The luminal epithelial cells were simple 
columnar with oval nuclei, basally disposed. A microvillus border was 
visible at the apical pole of these cells.  Vacuoles were not present in 
the cytoplasm (Fig. 21). Uterine glands were numerous with simple 
cuboidal epithelial cells and large basally placed nuclei. No vacuoles 
were present in the glandular epithelial cells (Fig. 22). 
 
In some hyperstimulated animals at 5.5 days of pregnancy, 
unattached embryos were present, situated close to the luminal 
epithelium (Fig. 23).  
 
Differences were observed in the morphology of the glands of 
hyperstimulated animals between 5.5 and 6.5 days of pregnancy. The 
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glands in the 5.5 and 6.5 day hyperstimulated animals had lumina 
which were more dilated (Fig. 22) than the lumina of the glands in the 
control groups at the same stages of pregnancy (Fig. 17). 
 
3.4. IMMUNOHISTOCHEMISTRY 
 
3.4.1. Controls for TGF β1 and TGF β2 immunohistochemistry 
 
 
 
Mouse ovary was used as a positive control for both TGF β1 and TGF 
β2, since this tissue is known to express the above-mentioned growth 
factors (personal communication with Santa Cruz Biotechnology 
support group). Immunoperoxidase staining for the mouse ovarian 
tissue showed extracellular localization of both TGF β1 (Fig. 24) and 
TGF β2 (Fig. 25) as expected.   
  
To confirm the specificity of immunolocalization of both TGF β1 and 
TGF β2, negative controls were included. Negative control sections 
were carried out on an adjacent section to a section of the uterine 
tissue which showed immunolocalization for that specific antibody. No 
immunolocalization was found in any of the tissue sections where 
primary or secondary antibody was omitted and replaced with either 
TBS (compare Figs. 27 and 28 with 26 and Figs. 30 and 31 with 29) or 
NRS (compare Fig. 33 with 32 and Fig. 35 with 34). 
 
To show the specificity of the primary antibodies, absorption 
controls were performed. These were carried out on a section of 
uterus adjacent to a section that showed immunolocalization. The 
results obtained showed a significant reduction in the case of TGF β1 
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antibody in the uterine tissue (Figs. 36a and 36b), while the 
absorption control for TGF β2 antibody showed no immunolocalization 
(Figs. 36c and 36d).  
 
According to the information provided by Santa Cruz Biology technical 
service (personal communications), both TGF β1 and TGF β2 antibodies 
are very “strong” antibodies. Thus “the complete disappearance of the 
immunolocalization should only be expected after the increase of the 
blocking peptide concentration to 10 or even 25 x (by weight)”. 
Following  the recommendation of Santa Cruz, the complete 
blocking/absorption was not achieved in the case of TGF β1 antibody, 
despite the fact that the amount of blocking peptide was increased 25x 
(by weight) (compare Figs. 36 a and 36b). A slight residue remained. 
 
  
3.4.2. Immunolocalization of TGFβ1 in control and 
hyperstimulated animals at 4.5, 5.5 and 6.5 days of pregnancy 
 
 
The distribution of TGF β1 immunolocalization differed between the 
control and hyperstimulated groups of animals at different stages of 
pregnancy. 
 
At 4.5 days of pregnancy in control animals, TGF β1 
immunolocalization was weak in both the luminal and glandular 
epithelial cells (Fig. 37). However, it was evident in the stromal 
compartment (Fig. 37). Subluminal stromal cells at the 
antimesometrial side showed stronger expression of TGF β1 than those 
at the mesometrial side of the lumen (figure not shown). The 
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myometrium of 4.5 days hyperstimulated animals had a weak 
expression of TGF β1 (figure not shown). 
 
 
The TGF β1 immunolocalization in the 4.5 days hyperstimulated 
animals was weak in the luminal and glandular epithelium (Fig. 37). 
Apical localization of TGF β1 was observed in both the luminal and 
glandular epithelial cells (Figs. 38 and 39). There was a distinct 
separation of the immunolocalization of TGF β1 into two regions in the 
stroma of 4.5 days pregnant hyperstimulated animals. The 
immediately subluminal zone had a weaker immunolocalization of TGF 
β1 while the deeper stromal region had a more concentrated expression 
(Fig. 38). This kind of regional separation in immunolocalization was 
not observed in the control group at 4.5 days of pregnancy (Fig. 37). 
There was no difference in TGF β1 immunolocalization between the 
antimesometrial and the mesometrial side of the lumen in the 
hyperstimulated group at 4.5 days of pregnancy (figure not shown). 
The myometrium of 4.5 days hyperstimulated animals had a weak 
expression of TGF β1 (figure not shown). 
 
There were no particular differences in TGF β1 expression in the 
luminal and glandular epithelial cells between the control and 
hyperstimulated groups at 4.5 days of pregnancy. TGF β1 
immunolocalization was weak in this region in both groups but with 
well defined apical localization (compare Figs. 37 and 38). However, 
differences were observed in the stroma in regard to regionalization. 
No difference in the intensity of the immunolocalization of TGF β1 was 
seen in the stroma of the control animals (compare with 4.5 day 
hyperstimulated animals, page 58). 
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At 5.5 days of pregnancy in control animals, TGF β1 
immunolocalization was weak in the luminal epithelium (Fig. 40) but 
more intense throughout the stromal compartment without showing 
regionalization (Figs. 40 and 41). In addition, the expression of TGF β1 
was stronger at the antimesometrial side of the lumen when compared 
to the mesometrial side (figure not shown). 
 
The TGF β1 immunolocalization in the 5.5 day hyperstimulated 
animals was weak in the luminal and glandular epithelium with well 
defined apical localization (Figs. 42 and 43). Regionalization i.e. the 
presence of two zones with different expression of TGF β1 was 
noticeable in the stroma (Fig. 42) while the myometrium showed weak 
expression. 
 
Thus, differences in TGF β1 expression between the control and 
hyperstimulated groups at 5.5 days of pregnancy existed 
particularly in the stromal compartment. Two zones of variation in TGF 
β1 expression i.e. subluminal zone with noticeably weaker TGF β1 
expression and deeper stromal zone where immunolocalization was 
more prominent, occurred in the stroma of the hyperstimulated 
animals (Fig. 42) but were not evident in  the control group at the 
same stage of pregnancy (Fig. 40).  
 
There was no difference in the expression of TGF β1 between 4.5 
and 5.5 days of pregnancy in the control groups. The luminal and 
glandular epithelium had a weak TGF β1 immunolocalization in both 
groups, while the stroma showed a stronger expression but without 
regionalization (Figs. 37, 38 and 41).  
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Also, there were no differences in the expression of TGF β1 
between 4.5 and 5.5 days of pregnancy in the hyperstimulated 
groups. Weak TGF β1 immunolocalization in the luminal and glandular 
epithelial cells existed in both stages of pregnancy (compare Figs. 38 
and 42). However, a well defined apical concentration was present in 
the luminal epithelium at both stages, as well as in the glandular 
epithelial cells at 4.5 days of pregnancy. Apical TGF β1 
immunolocalization was absent from the glandular epithelia of the 5.5 
days of pregnancy in the hyperstimulated group (compare Figs. 39 and 
43). Regionalization in the stromal compartment was also present in 
both 4.5 and 5.5 days of pregnancy in the hyperstimulated groups 
(Figs. 38 and 42). 
 
Luminal and glandular epithelial cells in both control and 
hyperstimulated groups at 6.5 days of pregnancy had weak TGF 
β1 expression (Figs. 46, 47, 48 and 49). The major difference in TGF β1 
expression between the control and hyperstimulated groups at 6.5 
days of pregnancy existed in the stromal compartment (Figs. 44 and 
48). The entire stroma of the 6.5 control group had weak TGF β1 
immunolocalization (Fig. 44). Only at the antimesometrial side was 
TGF β1 expression more apparent (Fig.45). However, two zones of TGF 
β1 expression were evident in the stroma of the hyperstimulated 
animals; the subluminal zone had weaker TGF β1 immunolocalization 
than the deeper, stromal zone (Fig. 48). This regionalization was not 
evident in the control group at the same stage of pregnancy (Fig.44). 
In the glands of control and hyperstimulated animals, the lumen 
contained some secretion which tended to take up the DAB chromagen 
(Figs. 47 and 49).  
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At 6.5 days of pregnancy in the vicinity of  implantation sites, 
localization of TGF β1 was evident in the stroma at the antimesometrial 
pole of the lumen and in the subluminal stromal cells surrounding the 
implanting conceptus (Figs. 44 and 45), while the stromal cells at the 
mesometrial pole did not show any TGF β1 immunolocalization (Fig. 
44). 
 
The expression of TGF β1 in the conceptus was localized to the 
trophoblast region, while the remainder of the embryo showed no 
immunolocalization of TGF β1    (Fig. 45). 
 
 
3.4.3. Immunolocalization of TGF β2 in control and 
hyperstimulated animals at 4.5, 5.5 and 6.5 days of pregnancy 
 
 
 
Immunolocalization of TGF β2 was evident in the tissue of both control 
and hyperstimulated animals at different stages of pregnancy. 
However, differences in the distribution of TGF β2 immunolocalization 
were evident between the two groups of animals. 
 
At 4.5 days of pregnancy in the control group of animals, TGF β2 
immunolocalization was strongly expressed in the cytoplasm of both 
the luminal and glandular epithelial cells (Figs. 50 and 51). Although 
immunolocalization of TGF β2 was observed in the stroma, it was 
noticeably weaker than that of the epithelium (Figs. 50 and 51). No 
apparent differences in the immunolocalization of TGF β2 were 
observed between the anti-mesometrial and mesometrial side of the 
lumen. 
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In the hyperstimulated animals at 4.5 days of pregnancy, the 
luminal epithelium showed a weak expression of TGF β2 which was 
mainly located in the apical region of these cells (Fig. 52). The 
glandular epithelium showed a strong immunolocalization of TGF β2 
(Fig. 53). The stromal compartment was separated into two zones on 
the basis of TGF β2 immunolocalization. The subluminal stroma had a 
weaker TGF β2 expression, while the deeper zone had a more intense 
immunolocalization (Fig. 52). 
 
The differences in TGF β2 expression between the control and 
hyperstimulated group at 4.5 days of pregnancy was particularly 
evident in the luminal epithelial cells and the subluminal stromal 
compartment (Figs. 50 and 52). While TGF β2 was intensely expressed 
in these areas in the control group, little immunolocalization occurred 
in these regions in the hyperstimulated group at the same stage of 
pregnancy (Figs. 50 and 52). The immunolocalization of TGF β2 in the 
glandular epithelial cells was similar in the two groups (Figs. 51 and 
53). 
 
At 5.5 day, a reduction in TGF β2 expression was obvious in the 
luminal epithelial cells in the control group when compared to the 4.5 
day control (Fig. 55). The immunolocalization of TGF β2 in the stroma 
was not as intense, when compared to that in the epithelium (Figs. 54 
and 55). Distinct expression of TGF β2 occurred in the glandular 
epithelium (Fig. 56). A difference in TGF β2 immunolocalization 
between the anti-mesometrial and the mesometrial side of the lumen 
was noticeable at 5.5 days of pregnancy in control animals (Fig. 54). 
In all the control animals at 5.5 days of pregnancy, strong TGF β2 
expression was evident in the myometrium of the uterus (Fig.  54). 
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In the hyperstimulated animals at 5.5 days of pregnancy, a 
strong apical localization of TGF β2 in the luminal epithelial cells was 
apparent (Fig. 58). Regionalization in the expression of TGF β2 was 
noticeable in the stroma. The zone immediately beneath the 
epithelium had scanty TGF β2 expression, while in the deeper stromal 
region immunolocalization appeared to be much stronger (Fig. 57). 
The expression of this growth factor was prominent in the glandular 
epithelium (Fig. 59). 
 
TGF β2 immunolocalization was also observed in the myometrium in 
the uterine tissue sections of 5.5 days hyperstimulated animals (figure 
not shown). 
 
Differences in TGF β2 expression between the control and 
hyperstimulated groups at 5.5 days of pregnancy thus existed in 
the luminal epithelium and subluminal stroma (Figs. 54, 55, 57 and 
58). The most obvious discrepancy was immunolocalization of TGF β2 
in the apical region of the luminal epithelial cells in the 
hyperstimulated animals (compare Figs. 55 and 58).  Regionalization 
in the expression of TGF β2 in the stroma of the hyperstimulated 
animals was another difference observed between the control and 
hyperstimulated groups at 5.5 days of pregnancy (compare Figs. 54 
with 57 and 55 with 58).    
 
At 6.5 days of pregnancy (control animals) a decrease in the 
localization of TGF β2 was apparent in the luminal epithelium, stroma 
and glandular epithelium (Figs. 60, 61 and 63) when compared to 5.5 
days control animals. However, TGF β2 immunolocalization remained 
strong in the myometrium (Fig. 60). In sections through the 
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implantation sites, stromal cells at the mesometrial site did not show 
any TGF β2 immunolocalization (Fig. 60), while those at the anti-
mesometrial side had evident expression of TGF β2 (Fig. 61). Glandular 
epithelium showed weak localization of TGF β2 (Fig. 63). 
 
At the implantation sites in 6.5 days pregnant animals, the 
implantation chamber had a heavy concentration of decidualizing 
stromal cells (Fig. 62). The blastocyst was elongated and adhered to 
both sides of the implantation chamber, almost entirely encompassed 
by the flattened luminal epithelial cells (Fig. 62). The location of the 
blastocyst was antimesometrial. 
 
The flattened luminal epithelial cells as well as the entire blastocyst did 
not show any immunolocalization of TGF β2 (Fig. 62). Intense TGF β2 
immunolocalization was expressed in the subluminal stroma 
surrounding the implanting conceptus (Fig. 62). 
 
 
Hyperstimulated animals at 6.5 days of pregnancy expressed 
TGFβ2 immunolocalization in the luminal epithelial cells concentrated at 
the apical pole (Fig. 65). Glandular epithelium in the hyperstimulated 
animals had strong TGF β2 immunolocalization (Fig. 65), while the 
stroma was divided into two zones by the intensity of 
immunolocalization of TGF β2. The subluminal zone was devoid of 
immunolocalization of TGF β2 while the deeper zone had scanty TGF β2 
immunolocalization (Fig. 64).  
 
Differences in TGF β2 expression between the control and 
hyperstimulated groups at 6.5 days of pregnancy thus existed in 
the luminal epithelium in which the localization of this growth factor in 
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the hyperstimulated group was more distinct and more apically 
pronounced (Fig. 65) than in the control group at the same stage of 
pregnancy (Fig. 61). TGF β2 immunolocalization was also more 
apparent in the glandular epithelium of the hyperstimulated animals at 
6.5 days of pregnancy, when compared to the controls (compare Figs. 
63 and 65). Control animals at 6.5 days of pregnancy did not show 
zonation in TGF β2 immunolocalization in the stroma, when compared 
to the hyperstimulated animals.  
 
Hyperstimulated animals at 6.5 days of pregnancy had a similar 
pattern of TGF β2 expression to hyperstimulated animals at 5.5 days of 
pregnancy, but this was expressed in a much weaker form (Figs. 57 
and 64). The luminal epithelial cells in the hyperstimulated animals at 
5.5 days of pregnancy had strong TGF β2 immunolocalization with 
prominent apical concentration (Fig. 58), while in animals at 6.5 days 
of pregnancy the immunolocalization in the same area was weaker 
with sparse apical localization (Fig. 65). Glandular epithelial cells had 
strong TGF β2 expression in the hyperstimulated animals in both 5.5 
days (Fig. 59) and 6.5 days of pregnancy (Fig.65). Immunolocalization 
in the stromal compartment was still divided into two zones at both 
5.5 days and 6.5 days of pregnancy in the hyperstimulated animals 
(Figs. 57 and 64). However, this regionalization was considerably 
weaker in the hyperstimulated animals at 6.5 days of pregnancy, 
where, in the subluminal zone, it reached the point of complete 
absence (compare Figs. 57 and 64).  
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3.4.4. Summary of the comparisons of immunolocalization 
between TGF β1 and TGF β2 in control and hyperstimulated 
animals 
 
 
 
The following differences were observed in the expression of TGF β1 
and TGF β2 when the 4.5, 5.5 and 6.5 days pregnant control and 
hyperstimulated rat uterine sections were compared: 
 
Immunolocalization of the TGF β1 in the luminal and glandular 
epithelium of both the control and hyperstimulated animals was weak 
and apically localized in all three examined stages of pregnancy. TGF 
β2 localization in the luminal and glandular epithelium decreased from 
4.5 to 6.5 days in the control group. However, while the expression of 
TGF β2 in the luminal epithelium was weak with distinct apical 
localization in all three examined stages of pregnancy in the 
hyperstimulated group, the glandular epithelium had strong expression 
of the TGF β2. 
 
Immunolocalization of TGF β1 in the stroma of the control animals was 
strong throughout all the examined stages of pregnancy, with no 
obvious regionalization. However, a gradual decrease in the 
localization of the TGF β2 was observed from 4.5 to 6.5 days of 
pregnancy in the stroma of the control animals. Immunolocalization of 
both TGF β1 and TGF β2 in the stroma of the hyperstimulated animals 
was regionalized into two zones, a subluminal zone with weak 
immunolocalization and deeper stromal region which expressed 
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stronger immunolocalization in all three examined stages of 
pregnancy. 
 
Immunolocalization of the TGF β1 in the myometrium was weak in the 
control as well as hyperstimulated groups in all the examined stages of 
pregnancy. However, immunolocalization of TGF β2 in the myometrium 
was strong in the control and hyperstimulated animals throughout the 
peri-implantation period. 
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Figure 1. Representative photograph of dissected uterine horns of a control animal (5.5 day 
of pregnancy). Note the presence of numerous blue bands (Implantation sites, 13 in total). 
Ovaries appear small and rounded. Pontamine blue staining reaction. 
 
 
Figure 2. Representative photograph of dissected uterine horns of a hyperstimulated animal 
(5.5 day of pregnancy). Note the dilated uterine horns and no evidence of blue stained 
implantation sites. Ovaries appear large with numerous follicles. Pontamine blue staining 
reaction. 
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Figure 3. A graph representing progesterone concentrations (ng/ml) in control and 
hyperstimulated animals on different days of pregnancy  
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Figure 4. A graph representing oestrogen concentrations (pg/ml) in the control and 
hyperstimulated animals on different days of pregnancy 
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Figure 5. A graph representing the ratio between progesterone and oestradiol plasma 
concentrations (P:E2 x 10
-3) in control and hyperstimulated animals on different days of 
pregnancy 
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Figure 6. A graph representing the interaction between progesterone (ng/ml) and oestradiol 
(pg/ml) concentrations ratio in the control and hyperstimulated animals at different stages of 
pregnancy. 
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Figure 7. Representative histological section of the 4.5 day control uterine tissue. Note the 
wavy outline of the luminal surface (LE) and numerous uterine glands (GL) in the stroma (ST). 
L-uterine lumen. Haematoxylin and eosin stain. x100 
 
 
Figure 8.  Representative histological section of 4.5 day control uterine tissue. Note the 
simple columnar luminal epithelial cells (LE) with round to oval, centrally placed nuclei (N), 
apical microvilli (MV) and vacuoles (V) in the base of the epithelial cells.  Also note the flat and 
fibroblastic (arrow) cells in the stroma (ST). L-uterine lumen. Haematoxylin and eosin stain. 
x400 
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Figure 9. Representative histological section of 4.5 day control uterine tissue at the 
antimesometrial pole. Note the simple cuboidal glandular epithelial cells (GE) with round to 
oval centrally placed nuclei (N) and vacuoles basally disposed (V). Note several round cells 
with distinct round nuclei, indicating that decidualization had begun (arrow). Note the 
presence of vacuoles (V) in the base of the luminal epithelial cells (LE).  Haematoxylin and 
eosin stain. x400 
 
Figure 10.  Representative histological section of 4.5 day hyperstimulated uterine tissue. 
Note that the luminal epithelium (LE) is thrown into folds. Several glands (GL) are present in 
the stroma (ST). L-lumen. Haematoxylin and eosin stain. x100 
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Figure 11.  Representative histological section of 4.5 day hyperstimulated uterine tissue. 
Note the simple columnar luminal epithelium (LE) with apical microvillus border (MV) and 
large oval, basally placed nuclei (N). The majority of subepithelial stromal cells (ST) appear 
flat and fibroblastic (arrow). Haematoxylin and eosin stain. x400  
 
Figure 12.    Representative histological section of 4.5 day hyperstimulated uterine tissue. 
Note the presence of glands (GL) in the subepithelial stroma (ST) which is populated by flat, 
fibroblastic cells. The simple cuboidal glandular epithelium (GE) has large, round to ovoid 
and basally placed nuclei (N) and an absence of vacuoles. Haematoxylin and eosin stain. 
x400 
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Figure 13.   Representative histological section of 5.5 day control uterine tissue. Note the 
smooth luminal surface and decidualization (DEC) of the subepithelial stromal cells. 
Haematoxylin and eosin stain. x100 
 
 
Figure 14.    Representative histological section of 5.5 day control uterine tissue. Note the 
opposite uterine walls in the vicinity of the implanting embryo (EMB) are more closely 
positioned to each other than in the 5.5 control animal in Fig. 9. BV-blood vessels. 
Haematoxylin and eosin stain. x100 
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Figure 15.    Representative histological section of 5.5 day control uterine tissue.  Magnified 
view of the figure 14 to show an embryo (EMB) attached to one side of the luminal epithelium 
(LE) at the antimesometrial side (AMM). Also note the luminal epithelial cells appear reduced in 
size (arrow) and layered (thick arrow). Haematoxylin and eosin. x1000  
 
 
Figure 16.    Representative histological section of 5.5 day control uterine tissue showing 
decidual cells (DEC) with round nuclei (N) and scanty cytoplasm.  Occasional blood vessels 
(BV) are visible in the subepithelial compartment. V-vacuoles.  Haematoxylin and eosin 
stain. x400 
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Figure 17.   Representative histological section of 5.5 day control uterine tissue showing 
clusters of uterine glands (GL). Note simple cuboidal glandular epithelium (GE) with centrally 
placed, round and basophilic nuclei (N).  Haematoxylin and eosin stain. x400 
 
 
Figure 18.    Representative histological section of 6.5 day control uterine tissue showing 
the simple cuboidal and simple squamous (antimesometrial side) shape of the luminal 
epithelial cells (LE). Note the well defined decidual cells with round nuclei (arrow) at the 
antimesometrial side (AMM). Haematoxylin and eosin stain. x400 
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Figure 19.   Representative histological section of 6.5 day control uterine tissue. Note the 
change in the shape of the luminal epithelial cells (LE) from simple cuboidal to columnar at 
the mesometrial side of the lumen (MM). BV-blood vessel. Haematoxylin and eosin stain. 
x400  
 
 
Figure 20.     Representative histological section of 5.5 day hyperstimulated uterine tissue 
showing extensively folded luminal epithelium (LE). Haematoxylin and eosin stain. x100 
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Figure 21.  Representative histological section of 5.5 day hyperstimulated uterine tissue 
showing simple columnar luminal epithelial cells (LE) with oval nuclei (N), basally disposed. 
A microvillus border (MV) is visible at the apical pole of these cells.  Vacuoles are not present 
in the cytoplasm. Haematoxylin and eosin stain. x400 
 
 
Figure 22.  Representative histological section of 5.5 day hyperstimulated uterine tissue. 
Uterine glands (GL) are observed in the stromal compartment (STR) filled with glandular 
secretion. Note the simple, cuboidal glandular epithelial cells (GE) with large basally placed 
nuclei (N). Haematoxylin and eosin stain. x400 
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Figure 23.  Representative histological section of 5.5 day hyperstimulated uterine tissue. 
Note the presence of incomplete (due to the sectioning) and unattached embryo (EMB) 
situated close to the luminal epithelium (LE). Haematoxylin and eosin stain. x400 
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Figure 24.  Mouse ovary, positive control. Photomicrograph of a histological section of 
mouse ovary incubated with TGF β1. Note extracellular (arrow) immunolocalization of TGF β1 
(arrow). x400 
 
 
Figure 25.   Mouse ovary, positive control. Photomicrograph of a histological section of 
mouse ovary incubated with TGF β2. Note extracellular immunolocalization of TGF β2 (arrow). 
x400 
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Figure 26.   Photomicrograph of the 
control uterine tissue incubated with 
TGF β1 antibody, showing cytoplasmic 
immunolocalization in the apex of the 
luminal epithelial cells and subluminal 
stroma (arrow). Counterstained with 
haematoxylin. x100   
 
 
Figure 27.   Photomicrograph of the 
control uterine tissue where primary 
antibody was omitted and replaced 
with TBS. Note absence of the TGF β1 
immunolocalization. Counterstained 
with haematoxylin. x100 
 
 
Figure 28.  Photomicrograph of the 
control uterine tissue where 
secondary antibody was omitted and 
replaced with TBS. Note absence of 
the TGF β1 immunolocalization. 
Counterstained with haematoxylin. 
x100 
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Figure 29.   Photomicrograph of the 
hyperstimulated uterine tissue 
incubated with TGF β2 antibody, 
showing TGF β2 immunolocalization in 
the luminal (arrow) and glandular 
epithelial cells (arrow). Counterstained 
with haematoxylin. x400   
 
 
Figure 30.   Photomicrograph of 
hyperstimulated uterine tissue where 
the primary antibody was omitted 
and replaced with TBS. Note absence 
of the TGF β2 immunolocalization. 
Counterstained with haematoxylin. 
x400 
 
 
 
Figure 31.   Photomicrograph of 
hyperstimulated uterine tissue where 
the secondary antibody was omitted 
and replaced with TBS. Note absence 
of the TGF β2 immunolocalization. 
Counterstained with haematoxylin. 
x400 
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Figure 32.   Photomicrograph of the 
control uterine tissue incubated with TGF β1 
antibody. Note TGF β1 immunolocalization 
in the subluminal stroma (arrow).  
Counterstained with haematoxylin. x400  
 
 
Figure 33.  Photomicrograph of control 
uterine tissue where primary antibody was 
omitted and replaced with NRS. Note the 
absence of TGF β1 in the luminal epithelium 
and stroma. Counterstained with 
haematoxylin. x400 
 
 
Figure 34.  Photomicrograph of the 
hyperstimulated uterine tissue incubated 
with TGF β2 antibody. Note luminal and 
glandular (arrow) TGF β2 
immunolocalization. Counterstained with 
haematoxylin. x400 
 
 
Figure 35.  Photomicrograph of the 
hyperstimulated uterine tissue where 
secondary antibody was omitted and 
replaced with NRS. Note absence of TGF β2 
immunolocalization. Counterstained with 
haematoxylin. x400 
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36 a. 
 
 
 
Figure 36 a and b.  Photomicrograph of 
control uterine tissue where an absorption 
control for TGF β1 was performed. Note TGF 
β1 immunolocalization in the stroma (Fig. 31 
a) and the marked reduction of TGF β1 
immunolocalization in the section in which 
the blocking of the primary antibody was 
performed (Fig. 31b).  Counterstained with 
haematoxylin. x400  
36 b. 
 
 
 
 
Figure 36 c and d.  Photomicrograph of 
hyperstimulated uterine tissue where the 
absorption control for TGF β2 was 
performed. Note immunolocalization in the 
luminal (arrow) and glandular (arrow) 
epithelium (Fig. 31 c) and no 
immunolocalization in the section where 
complete absorption was achieved (Fig. 31 d). 
Counterstained with haematoxylin. x400 
 
36 c. 
 
 
36 d. 
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Figure 37.   Representative section of 4.5 day control animal. Note the weak cytoplasmic 
immunolocalization of the TGF β1 in the luminal (LE) and the glandular (GE) epithelial cells 
and the stronger immunolocalization in the stroma (ST). Also note apical immunolocalization 
of the TGF β1 in the luminal epithelial cells (arrow). MV-microvillus border. Counterstained 
with haematoxylin. x400 
 
 
Figure 38.  Representative section of 4.5 day hyperstimulated animal. Note the weak 
TGFβ1 immunolocalization in the luminal epithelium (LE) with distinct apical concentration 
(arrow). Two regions (ST-1 and ST-2) of different TGF β1 immunolocalization in the stroma 
were apparent. Counterstained with haematoxylin. x400 
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Figure 39.   Representative section of 4.5 day hyperstimulated animal. Note the weak 
TGFβ1 immunolocalization in the glandular epithelium (GE) with apical concentrations 
(arrow), surrounded with stromal, deeper region (ST-2), which has strong TGFβ1 expression. 
Counterstained with haematoxylin. x400 
 
 
Figure 40.  Representative section of 5.5 day control animal. Note apical (arrow) TGF β1 
immunolocalization in the luminal epithelial cells (LE) and strong subluminal stromal TGF β1 
localization (ST). Counterstained with haematoxylin. x400 
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Figure 41. Representative section of 5.5 day control animal. Note the weak TGF β1 
immunolocalization in the glandular epithelium (GE) surrounded by stromal deeper region 
(ST-2) with strong TGF β1 immunolocalization. Counterstained with haematoxylin. x400 
 
 
Figure 42.   Representative section of 5.5 day hyperstimulated animal. Note the weak 
TGF β1 immunolocalization in the luminal epithelium (LE) with well defined apical 
localization (arrow). Two zones of immunolocalization in the stroma can be observed (ST-1 
and ST-2). Counterstained with haematoxylin. x400 
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Figure 43.  Representative section of 5.5 day hyperstimulated animal. Note the weak TGF 
β1 immunolocalization in the glandular epithelium (GE) and strong in the stroma (ST). 
Counterstained with haematoxylin. x400 
 
 
Figure 44.   Representative section of 6.5 day control animal. Note the embryo (EMB) 
lying unattached in the uterine lumen (L) and the opposite sides of the luminal epithelium 
(arrow) positioned closer to each other. Also note the strong TGF β1 immunolocalization at 
the antimesometrial pole (AMM) and weaker TGF β1 expression in the surrounding stroma 
(ST). MM-mesometrial pole. Counterstained with haematoxylin. x100  
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Figure 45.   Representative section of 6.5 day control animal (antimesometrial side). Note 
TGF β1 immunolocalization in the trophoblast (TB) of the implanting embryo (EMB). Also 
note strong TGF β1 immunolocalization at the antimesometrial (AMM) pole surrounding the 
implanting conceptus. Counterstained with haematoxylin. x400 
 
Figure 46.   Representative section of 6.5 day control animal. Note the weak TGF β1 
expression in the luminal epithelium (LE). Note the subluminal TGF β1 immunolocalization at 
the antimesometrial pole (AMM). Counterstained with haematoxylin. x400 
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Figure 47.  Representative section of 6.5 day control animal. Note weak TGF β1 expression 
in the glandular epithelium (GE) and secretion in the lumina of the glands which took up the 
DAB chromagen (arrow). ST-stroma. Counterstained with haematoxylin. x400 
 
 
Figure 48.   Representative section of 6.5 day hyperstimulated animal. Note two distinct 
zones of TGF β1 immunolocalization in the stroma, the weak ST-1 and strong, deeper zone 
ST-2. Counterstained with haematoxylin. x100 
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Figure 49.   Representative section of 6.5 day hyperstimulated animal. Note the weak TGF 
β1 immunolocalization in the glandular epithelium (GE) surrounded by the deeper region of 
the stroma, which has a stronger expression of TGF β1. Also note the lumen with secretion 
(arrow) which took up the DAB chromagen. Counterstained with haematoxylin. x400  
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Figure 50.  Representative section of 4.5 day control animal. Note the strong TGF β2 
immunolocalization in the luminal epithelial cells (LE). ST- stroma, L-lumen. Counterstained 
with haematoxylin. x400   
 
 
 
Figure 51.  Representative section of 4.5 day control animal. Note the intense cytoplasmic 
TGF β2 immunolocalization in the glandular epithelial cells (GE) and luminal epithelial cells 
(LE). ST-stroma. Counterstained with haematoxylin. x400 
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Figure 52.  Representative section of 4.5 day hyperstimulated animal. Note the weak TGF 
β2 immunolocalization in the luminal epithelial cells (LE), which was mostly concentrated at 
the apical pole of these cells (arrow). Also note the regionalization into two zones (ST-1 and 
ST-2) was present in the stroma. L-lumen. Counterstained with haematoxylin. x400 
 
 
Figure 53.  Representative section of 4.5 day hyperstimulated animal. Note the strong TGF 
β2 immunolocalization in the glandular epithelial cells (GE) which appear more dilated than 
those in the control group at the same stage of pregnancy. ST-stroma. Counterstained with 
haematoxylin. x400 
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Figure 54.   Representative section of 5.5 day control animal. Note the difference in TGF β2 
immunolocalization between the anti-mesometrial (AMM) and the mesometrial (MM) side of 
the lumen. L-lumen, MY-myometrium. Counterstained with haematoxylin. x100. 
 
 
 
Figure 55. Representative section of 5.5 day control animal. Note cytoplasmic 
immunolocalization of TGF β2 in the luminal epithelial cells (LE) and stroma (ST) which 
appeared weaker when compared to the same group of cells at 4.5 day of pregnancy (see 
Fig.  41). L-lumen. Counterstained with haematoxylin. x400  
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Figure 56.  Representative section of 5.5 day control animal. Note distinct TGF β2 
immunolocalization in the glandular epithelial cells (GE). ST-stroma. Counterstained with 
haematoxylin. x400. 
 
 
 
 
 
Figure 57.   Representative section of a 5.5 day hyperstimulated animal. Note weak TGF 
β2 immunolocalization in the luminal epithelium (LE) and first zone of subluminal stroma (ST-
1)) and the much stronger localization in the deeper, second zone (ST-2). L-lumen. 
Counterstained with haematoxylin. x100. 
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Figure 58.   Representative section of 5.5 day hyperstimulated animal. Note the strong 
apical TGF β2 immunolocalization (arrow) in the luminal epithelial cells (LE) and scanty TGF 
β2 expression in the subluminal stromal zone (ST -1). ST-2- deeper, stromal zone. L-lumen. 
Counterstained with haematoxylin. x400. 
 
Figure 59.   Representative section of a 5.5 day hyperstimulated animal. Note strong 
immunolocalization of TGF β2 in the glandular epithelium (GE). ST-stroma. Counterstained 
with haematoxylin. x400. 
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Figure 60.  Representative section of 6.5 day control animal. Note weak TGF β2 
immunolocalization in the luminal epithelium (LE) and stroma (ST) and strong TGF β2 
immunolocalization in the myometrium (MY). AMM-anti-mesometrial side and MM-
mesometrial side of the lumen. L-lumen. Counterstained with haematoxylin. x100 
 
 
Figure 61. Representative section of 6.5 day control animal. Note TGF β2   
immunolocalization at the anti-mesometrial side (AMM) of the lumen and scanty apical 
expression (arrow) in the flattened luminal epithelial cells (LE). L-lumen, ST-stroma. 
Counterstained with haematoxylin. x400 
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Figure 62.  Representative section of a 6.5 day control animal. Note an implantation 
chamber with an implanted embryo (EM) adhering to both sides of the implantation chamber 
and encompassed entirely by the flattened luminal epithelial cells (LE).Also note strong TGF 
β2  immunolocalization of in the subluminal stroma (ST) surrounding the implanting 
conceptus. Counterstained with haematoxylin. x400 
 
 
Figure 63.   Representative section of a 6.5 day control animal. Note the weak the TGF β2 
immunolocalization in both the glandular epithelium (GE) and stroma (ST). Counterstained 
with haematoxylin. x400 
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Figure 64.  Representative section of 6.5 day hyperstimulated animal. Note TGF β2 
immunolocalization in the stroma is divided into two zones ST-1 –first zone with no TGF β2 
immunolocalization and ST-2 second, deeper zone with scanty TGF β2 expression. L-lumen. 
Counterstained with haematoxylin. x100  
 
 
Figure 65.   Representative section of 6.5 day hyperstimulated animal. Note apical TGF β2 
concentration (arrow) in the luminal epithelial cells (LE) and strong cytoplasmic TGF β2 
immunolocalization in the glandular epithelium (GE). ST-stroma. Counterstained with 
haematoxylin. ST-stroma. x400 
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4.  DISCUSSION 
 
 
 
Administration of exogenous gonadotropins in phase with the oestrus 
cycle of the rat was achieved by successful ovarian hyperstimulation. 
The latter was indicated by the enlarged ovaries with numerous large 
follicles and noticeably dilated uterine horns. These changes were not 
observed in the control groups at all of the examined stages of 
pregnancy. 
 
Round ovaries and non-dilated uterine horns which contained 
implantation sites and which were evident in all the control animals, 
contrasted strongly with the majority of the hyperstimulated animals 
in which implantation sites were not observed. However, two animals 
in the hyperstimulated group at 5.5 days of pregnancy showed one 
visible implantation site per animal. There were no other blue bands 
(implantation sites) present in the remainder of the uterine horns in 
both of these hyperstimulated animals.  
  
The incidence of the implantation sites and implanting embryos within 
the control uterine horns in the present study, support the hypothesis 
that the blastocysts within the uterine lumen are a stimulus which 
results in an increase in the permeability of endometrial capillaries 
(Psychoyos, 1973). If a macromolecular dye such as pontamine blue is 
injected intravenously around the peri-implantation period, it will leave 
the circulation only in areas where permeability of capillaries is greatly 
increased (Psychoyos, 1973). This method has been widely used to 
localize implantation sites, which appear as distinctive blue bands at 
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the sites of embryo implantation 15 minutes after the pontamine blue 
injection (Finn and Porter, 1975). Therefore, the pontamine blue 
reaction was not completely inhibited in two hyperstimulated animals 
at 5.5 days of pregnancy, in which one implantation site was present 
in each animal. In these two hyperstimulated animals, unattached 
embryos were found in the uterine lumina, but implanting embryos 
were never located. The possible reason for this exception could be the 
alteration in the hormonal levels known to occur in hyperstimulated 
animals (Kramer et al., 1990), their detrimental effect on the 
morphology of the endometrium as well as on the passage of the ova 
down the uterine tubes (Kramer et al., 1993) and an individual 
response of these animals to the abovementioned changes, that had 
altered the endocrine environment and uterine morphology due to the 
supraphysiological hormonal environment. 
 
 
4.1. Dating of pregnancy 
 
 
The presences of either a vaginal plug on the morning following mating 
or spermatazoa in a vaginal smear are used as markers of successful 
impregnation. Although the markers of pregnancy are indisputable, the 
dating of pregnancy varies within published studies. In the current 
study, the presence of the mentioned markers on the morning 
following mating is referred to as day 0.5 of pregnancy (Stein and 
Kramer, 1989; Kramer et al., 1993). As the animals mate around 8 
p.m. and are killed at approximately 8 a.m. the following morning, the 
dating of pregnancy is held to be approximately 12 hours or 0.5 day of 
pregnancy. This contrasts with other studies which refer to this 
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occurrence as day 1 of pregnancy (Enders and Schlafke, 1967; 
Psychoyos, 1973; Lundkvist and Ljungkvist, 1977). This discrepancy 
should be taken into consideration during the ensuing chapters, in 
which comparisons are made between the results of this study and 
published material.  
 
 
4.2. The effects of hyperstimulation on progesterone and 
oestrogen levels 
 
 
The preparation of the endometrium for receipt of the embryo is 
dependent on the ovarian hormones, oestrogen and progesterone. In 
this study, the secretion of oestrogen and progesterone from the 
ovaries was affected by the administration of exogenous 
gonadotropins, which had been superimposed upon the normal 
hormonal levels of the intact animal. As a consequence, the release of 
ovarian steroids in the hyperstimulated animals was altered, causing a 
change in the endogenous hormonal environment, which severely 
affected the number of the implanting embryos and thus the 
pregnancy outcome. 
 
The progesterone plasma concentrations showed an increase from 
4.5 to 5.5 days of pregnancy in the control group, followed by a 
sudden drop at 6.5 days. The hyperstimulated group showed a gradual 
increase from 4.5 to 6.5 days of pregnancy. When comparisons were 
made between the control and the hyperstimulated groups at all three 
stages of pregnancy, the values of progesterone were higher in the 
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latter group, but statistically significantly higher only at 6.5 days of 
pregnancy.  
 
Many controlled ovarian hyperstimulation cycles are associated with 
the early expression of endometrial histological features, the change in 
the expression of oestrogen and progesterone receptors and the shift 
in the timing of pinopode appearance (Develioglu et al., 1999; Lessey, 
2001a; Lessey, 2001b; Murphy, 2004). The above mentioned signs of 
hyperstimulation are said to be caused by the high levels of 
progesterone following hCG administration (Develioglu et al., 1999). 
Additionally, the appearance of pinopodes observed within the limited 
time of 24-48h in mammals, is an indicator of the window of 
implantation (Nikkas et al., 1995; Murphy, 2004) and depends on the 
ovarian hormones, especially progesterone (Singh et al., 1996). 
Moreover, premature elevations in plasma progesterone levels, after 
routine use of hCG in IVF and ET programs, induces an unexpected 
and greatly increased secretion of progesterone (Taieb et al., 1997). 
This sudden shift in progesterone level accelerates the secretory 
changes of the endometrium to the point of phasing out endometrial 
receptivity and embryo development (Taieb et al., 1997). As 
progesterone levels increased in the hyperstimulated animals during 
the peri-implantation period, it is postulated that this event could have 
shifted the window of implantation earlier in the treated animals, thus 
causing dyssynchrony between the maturity of the embryo and 
receptivity of the endometrium.  
 
The oestradiol plasma concentrations showed an increase from 4.5 to 
6.5 days of pregnancy in the control group. Following 
hyperstimulation, the oestradiol plasma levels increased from 4.5 to 
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5.5 days of pregnancy followed by a sudden drop from 5.5 to 6.5 days 
of pregnancy. When comparisons were made between the control and 
the hyperstimulated group, higher oestradiol concentrations were 
evident in the treated group but a statistically significant difference 
was only found at 6.5 days of pregnancy.  
 
The findings of the present study on high oestrogen levels in the 
hyperstimulated animals are consistent with Ma et al. (2003), who 
showed that the uterus becomes refractive after raised oestrogen 
levels due to ovarian hyperstimulation procedures. On the other hand, 
in their work, Simón et al. (1998) compared the effects of a standard 
ovarian hyperstimulation protocol to the step-down regimen in which 
the patient received different gonadotropin doses prior to IVF 
treatment. The outcome was that the implantation and pregnancy 
rates were significantly improved in the patients who underwent the 
step-down procedure. Simón et al. (1998) indicated that the 
implantation rates could be improved when oestrogen levels are 
decreased during the pre-implantation period.  In addition, Kramer et 
al. (1990) investigated the effects of exogenous gonadotropins on the 
rat endometrial morphology. They found that these hormones 
produced a number of significant changes, such as an increase in 
luminal and glandular epithelial height, an increase in the number and 
length of microvilli, a decrease in the glycocalyx, and a decrease in 
mitotic activity in the surface epithelial cells as well as the stromal 
cells. Similarly, Basir et al. (2001) morphometrically examined the 
peri-implantation endometrium in patients undergoing IVF treatment. 
They found that increased levels of oestradiol significantly alter 
endometrial morphological features and transform the endometrium, 
causing decreased implantation and pregnancy rates. The data of the 
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present study in which higher oestrogen levels have been shown in 
hyperstimulated animals are consistent with the work done by Simón 
et al. (1998) and Basir et al. (2001). It is thus postulated that the 
absence of implantation sites in the majority of the treated animals 
could be due to the change in the oestrogen levels following ovarian 
hyperstimulation and its effect on vascular permeability and 
decidualization of the subepithelial stromal cells. 
 
Ma et al. (2003) offered another possible explanation for inhibition of 
implantation in the hyperstimulated animals. In their work using a 
progesterone-treated delayed-implantation model in mice, Ma et al. 
(2003) provided evidence that levels of oestrogen in a very narrow 
range, such as 3 ng, establish the duration of the window of uterine 
receptivity for implantation. In animals with high oestrogen levels e.g. 
10-25 ng, the uterus was rapidly transformed from a receptive into a 
refractive state, suggesting an intense sensitivity of the uterus to 
oestrogen levels. Our findings in which higher oestradiol 
concentrations occurred in hyperstimulated animals at all stages of 
pregnancy when compared to those in the control groups support the 
work of Ma et al. (2003). The increased levels of oestrogen after 
ovarian hyperstimulation in the present study appear to have 
narrowed the window of implantation in the treated animals and led 
the uterus into a refractive state.  
 
Following hyperstimulation, oestradiol levels were increased prior to 
implantation (day 5.5), followed by a rapid decrease at 6.5 days of 
pregnancy. The progesterone plasma concentrations were also affected 
by the treatment and showed a gradual increase from 4.5 day 
onwards. Consequently the P:E2 ratio was lower in the 
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hyperstimulated group than in the control animals before implantation, 
and only statistically significantly higher at 6.5 days of pregnancy. 
According to Gidley-Baird et al. (1986) alterations in oestrogen and 
progesterone levels affect the reproductive outcome, but the P:E2 ratio 
better predicts the implantation outcome than the absolute levels of 
either oestrogen or progesterone alone (Gidley-Baird et al., 1986;  Ma  
et al., 2003). The present study is consistent with the work previously 
done by Gidley-Baird et al. (1986) and Kramer et al. (1990) in which 
they showed that a change in the P:E2 ratio had detrimental effects on 
the number of implanting embryos in the mouse and rat respectively. 
In the present investigation the comparatively lower P:E2 ratio in the 
experimental groups at 4.5 and 5.5 days of pregnancy and the 
absence of a statistically significant difference in the P:E2 ratio at 4.5 
and 5.5 days of pregnancy in the hyperstimulated group support 
observations made by Gidley-Baird et al. (1986) and Kramer et al. 
(1990). 
 
Another approach for explaining the influence of the P:E2  ratio on the 
absence of implantation sites in hyperstimulated animals could arise 
from recent work by Ozcakir et al. (2004). They observed the outcome 
of premature luteinization which was defined as a progesterone-
oestradiol ratio > 1 on the day of hCG administration. Group A 
consisted of patients whose P:E2 ratio was 1 while Group B comprised 
patients with premature luteinization whose P:E2 ratio was >1. The 
primary outcome measure in this study by Ozcakir et al. (2004) was 
oocyte quality, fertilization rate and clinical pregnancy rate, which 
were all adversely affected by premature luteinization defined as P:E2 
ratio >1. Indeed, the pregnancy outcome of the present study could 
have been affected by the dominance of progesterone (P:E2>1) which 
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was observed at 5.5 and 6.5 days of pregnancy in the hyperstimulated 
animal.  
  
Although the aim of this investigation was to observe the effects of 
hyperstimulation on the endometrium, it is noteworthy that 
hyperstimulation has an influence on the embryo as well as other parts 
of the female reproductive tract. According to Fossum et al. (1988) 
and also Ertzeid and Storeng (2001) ovarian hyperstimulation has 
effects on oocyte and/or embryo quality, oviductal and/or uterine 
environment and synchrony, which normally exists between the 
embryo and the endometrium at the time of implantation. Taking 
advantage of the fact that the uterus in mice has two horns, Ertzeid 
and Storeng (2001) established an embryo transfer model in which 
they transferred the embryos from either superovulated or non-
stimulated females into separate uterine horns within the same 
superovulated or non-stimulated pseudopregnant recipients. The 
negative effect of ovarian hyperstimulation on oocyte/embryo 
development was observed, as a transfer of embryos from 
superovulated donors resulted in a significantly lower implantation rate 
in control recipients compared with that of embryos from control 
donors.  
 
Ertzeid and Storeng (2001) also observed the negative effect of 
ovarian hyperstimulation on uterine receptivity. They suggested that 
the exogenous gonadotropin hormones, by altering the concentrations 
of circulating oestrogen and progesterone, also affected the expression 
of locally produced endometrial cytokines and hence they affect 
endometrial receptivity.  Similarly, Klentzeris (1997) and Beier and 
Beier-Hellwig (1998) showed that progesterone and oestrogen mediate 
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their actions by locally produced cytokines which act in either an 
autocrine or paracrine manner. Beier and Beier-Hellwig (1998) 
explained that the endometrium requires cytokines to act locally or to 
mediate cell-to-cell communications thus regulating oestrogen and 
progesterone control of endometrial development and consequently 
embryo implantation.  
 
Furthermore, Van der Auwera et al. (1999) demonstrated that 
superovulation and subsequent high concentrations of steroids have 
detrimental effects on pregnancy outcome by causing hormonal 
stimulation of the oviductal milieu and in that way producing harmful 
changes to pronucleate ova as well as on the developmental capacity 
of the pre-implantation embryo. 
 
 
4.3. The effects of hyperstimulation on the histology of the rat 
uterine tissue 
 
 
Factors influencing endometrial receptivity in ovarian stimulation for 
IVF are still poorly understood (Bourgain, 2004).  The general trend 
that emerges from available studies shows that abnormalities in the 
luteal phase have been detected in almost all stimulation protocols 
used in in vitro fertilization programs, on both the hormonal and 
endometrial levels (Tavaniotou et al., 2001; Bourgain and Devroey, 
2003). Furthermore, it is a well known fact that IVF treatments are 
usually achieved through ovarian stimulation and are thus associated 
with supraphysiological serum concentrations of oestradiol and 
progesterone.  These conditions which have been forced upon the 
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intact animal in order to produce superovulation have their influence 
on the histology of the uterine tissue and as a consequence, on 
endometrial receptivity and embryo implantation. 
 
In the present study, the non-dilated uterine lumina and relatively 
smooth luminal epithelium in most of the control animals contrasted 
strongly with the grossly dilated lumina and exceptionally folded 
epithelium of the hyperstimulated animals. These changes are in 
agreement with findings made by Stein and Kramer (1989), Kramer et 
al. (1993) and Valbuena et al. (1999) whose results indicate both 
stimulation (dilatation of the uterine horns, accumulation of uterine 
fluid, changes in the luminal epithelial height and microvillus border) 
and damage (presence of necrotic and damaged cells) of the  
endometrium by the gonadotropic hormones. Additional differences 
were observed in the cytology of the epithelial cells in the current 
study. In the luminal and glandular epithelium, the position of the 
nuclei and vacuoles varied between the different groups. Also, the 
glands of the hyperstimulated animals had dilated lumina which were 
often filled with secretion when compared to the glands of the control 
groups, in which these glandular aspects were absent.  
 
Furthermore, in control animals, a gradual modification of luminal 
epithelial cell height starting from the mesometrial side and proceeding 
to the antimesometrial side was observed in control animals in the 
sections that were taken close to the implantation site. The 
implantation chamber containing the conceptus consisted of flattened 
luminal epithelial cells which were in a close association with the 
trophoblast cells (Murphy, 2004), and decidual cells, whose developing 
stages were more pronounced at the anti-mesometrial side of the 
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uterine lumen (Psychoyos, 1967; Welsh and Enders, 1983). This 
preparation of both the luminal epithelium and decidualizing stroma 
will consequently result in a displacement of the epithelium, which will 
further facilitate contact between the trophoblast and the maternal 
blood (Schlafke et al., 1985).  None of the above mentioned findings 
have been observed in the hyperstimulated animals in the present 
study, even though embryos were found in the lumen of the uteri of 
two hyperstimulated animals at 5.5 days of pregnancy. It is postulated 
that hyperstimulation had a negative effect in the preparation of the 
luminal epithelium as well as the trophoblast cells, thus preventing the 
events necessary for successful implantation. 
 
Hyperstimulation with gonadotropins caused increased uterine 
epithelial height (Nilsson, 1967) and increased mitotic activity of the 
luminal, glandular epithelial cells and stromal cells in the 
hyperstimulated animals (Finn and Martin, 1970). In gonadotropin 
agonist cycles, mid-luteal biopsies showed increased glandulo-stromal 
dyssynchrony and postponement in endometrial development, strong 
positivity of endometrial glands for progesterone receptors and 
advanced appearance of pinopodes of the surface epithelium 
(Tavaniotou et al. 2001). Additionally, an advanced maturation of the 
endometrium in the peri- and post-ovulatory period, followed by  
“normal” features of the endometrium in the early luteal phase, 
resulted in frequent glandulo-stromal dyssynchrony in the mid- and 
late luteal phase (Bourgain and Devroey, 2003). More specifically, 
advanced endometrial maturation was said to be present on the day of 
oocyte retrieval in IVF cycles, using either GnRH agonist or antagonist 
(Papanikolaou et al., 2005). In contrast, in natural cycles such an 
advancement of the endometrium is not present (Bourgain et al., 
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2002). Macklon et al. (2006) explained that in biopsies taken 7 days 
after ovulation from patients undergoing hyperstimulation for the IVF 
procedure, there is endometrial delay and glandular-stromal 
dissociation. It seems that stimulation with a GnRH agonist and 
gonadotropins induces early endometrial development with consequent 
glandular maturation arrest in the mid-luteal phase (Basir et al., 
2001). In the same study, Basir et al. (2001) further explained that 
the glands with varying luminal filling represent glands at different 
stages of secretory development and that each patient responds 
differently to the ovarian stimulation regimen. In high responders 
whose glandular secretion was disrupted, a prolonged retention and 
retarded emptying of the secretory material was present (Basir et al., 
2001).  
 
Further differences between control and hyperstimulated animals were 
found in the stroma in the present study. During the observed peri-
implantation period, the stromal cells of the control animals changed 
their shape from fibroblastic at 4.5 days of pregnancy, into round cells 
with scanty cytoplasm towards day 6.5 of pregnancy. By contrast, the 
majority of the stromal cells in the hyperstimulated animals remained 
flat and fibroblastic and the stromal tissue remained compact without 
any signs of decidualization throughout the peri-implantation period. 
 
Preparation of the endometrium as is reflected in its morphology is one 
of the crucial prerequisites for successful implantation (Schlafke and 
Enders, 1975; Psychoyos and Martel, 1985). In their work, Stein and 
Kramer (1989) and Kramer et al. (1990), showed that exogenous 
gonadotropins administered in phase with the oestrus cycle of the rat, 
cause numerous endometrial changes which affect the attachment and 
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implantation of the embryo. Hyperstimulation i.e. high levels of 
oestrogen, have harmful effects on the endometrial morphology such 
as increased stromal vascularity and luminal dilatation (Spaziani, 
1963), a decrease in the vascular permeability of the endometrium 
(Kramer, 1997) and an absence of decidualization of the subepithelial 
stromal cells (Stein and Kramer, 1989). Although detailed observations 
of stromal vascularity and vascular permeability were not included in 
the present study, similarities are present between results found in the 
current study and the findings of Kramer (1997). Firstly, the presence 
of the pontamine blue reaction in 4.5 (only one control animal), 5.5 
and 6.5 days control animals demonstrated an increase in the 
permeability of uterine vessels, which is according to Psychoyos 
(1973) an indispensable condition for deciduoma formation. Psychoyos 
(1984) also adds that any procedure that inhibits this increase in 
permeability also inhibits decidualization. Comparable observations 
were not seen in the hyperstimulated animals which indicated that the 
vascular permeability was suppressed with increased oestradiol and 
progesterone levels. Secondly, while the decidual reaction was 
observed in all of the control animals, a non-decidualized stroma was 
present in all the hyperstimulated animals. Thus, the absence of the 
pontamine blue reaction as well as the decidual reaction in the 
majority of the hyperstimulated animals provided additional evidence 
for yet another detrimental effect of hyperstimulation in the current 
study. 
 
In addition, another characteristic was observed in the control animals 
in this study, which demonstrated further development of the 
endometrium in the anticipation of embryo. “Spaces” which were 
evident between decidual cells of the stroma in control groups at 5.5 
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and 6.5 days of pregnancy are said to represent oedema (Psychoyos, 
1973). Oedema was not observed in the stroma of the hyperstimulated 
animals in this study.  According to Psychoyos (1973) oedema is the 
most pronounced transitional stromal change during the period of 
uterine receptivity. It occurs in the mid-luteal period independent of 
the presence of an implanting ovum (Psychoyos, 1973; Psychoyos, 
1984). Psychoyos showed that oedema occurs in rats on day 5 (day 
4.5 this study) of pregnancy and pseudopregnancy, and at about noon 
of the same day, develops into a widespread oedema dispersing the 
decidual stromal cells which results in the gradual obliteration of the 
uterine cavity. Shelesnyak (1957) followed the further events involved 
in the decidual cell reaction and found that histamine was involved in 
deciduogenesis through the activation of the relevant enzyme located 
in the endothelium of uterine capillaries.  Moreover, Dey et al. (1979) 
showed that endometrial cells contain histamine receptors. When 
histamine binds to the endothelial receptors it affects vasodilatation 
and influences vascular permeability. Histamine-induced vascular 
leakage is potentiated by prostaglandins which are involved in the 
initiation and differentiation of decidual cells (Kennedy, 1985). As a 
result of the decidual reaction as well as increased vascular 
permeability, the uterine lumen gradually becomes occluded, 
facilitating the primary contact between the blastocyst and the luminal 
epithelium (Psychoyos, 1973).  
 
In the two 5.5 day hyperstimulated animals in which the pontamine 
blue reaction was not completely inhibited, an unattached embryo was 
found in the lumen of each of the animals. However, other 
characteristics important for implantation, such as the decidual 
reaction, oedema and obliteration of the lumen, as well as close 
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contact of the opposite sides of the luminal epithelium were not 
observed in these animals. The above mentioned findings support the 
work by Kramer (1997), who showed that absence of decidualization in 
the rats that underwent ovarian hyperstimulation is due to a decrease 
in vascular permeability, which is an indispensable condition for 
deciduomata formation. 
 
In their study Ku et al. (2004) obtained endometrial stromal cells from 
patients undergoing hysterectomy procedures and cultured specimens 
in serum-containing media. They monitored the effects of different 
doses of human menopausal gonadotropin (hMG), FSH or hCG on 
cumulative radioactive thymidine incorporation into these endometrial 
stromal cells. The study demonstrated that hMG and FSH induced 
inhibition of radioactive thymidine incorporation into the endometrial 
stromal cells at all the concentrations used, while inhibition with hCG 
was dose dependant. Ku et al. (2004) postulated that gonadotropins 
inhibit proliferation of the human endometrial stromal cells in vitro, 
which has implications for endometrial receptivity and embryo 
implantation.    
 
 
4.4. The effect of hyperstimulation on the expression of TGF β1 
and TGF β2  
 
 
The findings of the present study showed marked differences in the 
expression of both TGF β1 and TGF β2 between the control and 
hyperstimulated animals. 
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Immunohistochemical comparisons of expression of TGF β1 between 
control and hyperstimulated animals revealed discrepancies in the 
stromal compartment. This segment of the uterine endometrium 
expressed strong and even TGF β1 immunolocalization in all three 
stages of pregnancy in the control groups, while hyperstimulated 
animals at all stages of pregnancy showed regionalization in the 
expression of TGF β1. Hyperstimulation appears to have caused two 
zones in the expression of TGF β1. The subluminal stromal zone had a 
weaker expression of TGF β1 in all the examined stages of pregnancy in 
the hyperstimulated animals, when compared to the deeper stromal 
zone, which strongly expressed this growth factor. The expression of 
TGF β1 in the luminal and glandular epithelium as well as myometrium 
did not differ between the control and hyperstimulated animals in all 
the examined stages of pregnancy. 
 
Compared to the TGF β1 findings, immunohistochemical comparisons of 
expression of TGF β2 between the 4.5, 5.5 and 6.5 days pregnant 
control and hyperstimulated animals did not show as marked 
differences in immunolocalization.  The control animals had a gradual 
decrease in the expression of TGF β2 in the luminal epithelium, 
glandular epithelium and the stroma, while myometrium showed 
strong immunolocalization of this growth factor. The most prominent 
effect of hyperstimulation was the presence of an increased expression 
of TGF β2 in the glandular epithelial cells in all examined stages of 
pregnancy. The immunolocalization of TGF β2 was not affected by 
hyperstimulation in the remainder of endometrium, apart from the 
stroma which also had regionalization in the expression of TGF β2. 
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The diversity in the expression of both TGF β1 and TGF β2 in the 
present study is not surprising, knowing that the transforming growth 
factors present multifunctional cytokines which are dynamically 
expressed in the endometrium. Through their actions TGF β’s are 
associated with cell proliferation, differentiation, apoptosis, 
angiogenesis, tissue remodeling and immune responses (Jones et al., 
2006). Because of the involvement that TGF β’s have in the cellular 
and molecular processes such as those mentioned above, these 
polypeptides have been said to play an important role in modulating 
cellular events involved in menstruation, decidualization, 
establishment of pregnancy, trophoblast attachment, immunotolerance 
and embryogenesis. They thus have been recognized as possible 
modulators of many endometrial functions (Godkin and Dore, 1998; 
Jones et al., 2006). Although TGF β isoforms overlap in their biological 
actions, their potencies may vary (Das et al. 1992). They also have 
unique roles in embryo-uterine interactions during implantation (Das 
et al. 1992). Oestrogen and progesterone have previously been shown 
to regulate changes in the endometrium and stroma of pregnant and 
non-pregnant uteri. The actions of these steroid hormones are usually 
not direct, but are mediated through their stimulatory or inhibitory 
effects upon different endometrial cells. This results in the control of 
autocrine/paracrine actions of TGF β’s. The hormones may also 
modulate the production of specific isoforms of TGF β’s (Tang et al., 
1994; Bruner et al., 1995; Robinson et al., 1996; Ashcroft et al., 
1997; Wira and Rossoll, 2003; Luo et al., 2004).  
 
In the present study, TGF β1 immunolocalization in the control animals 
had weak expression in the luminal and glandular epithelium with a 
distinct apical concentration, while stronger immunolocalization was 
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observed in the stroma throughout the peri-implantation period. TGF 
β2 showed a gradual decline in the luminal epithelium, stroma and 
glandular epithelium from 4.5, 5.5 and 6.5 days of pregnancy in the 
control animals. This is in accordance with Godkin and Dore (1998) 
who found TGF β1 present in both the epithelium and the stroma of the 
human endometrium during early pregnancy, while TGF β2 was 
predominantly localized in the stroma. Moreover, from their in vitro 
study which used monolayer cultures of endometrial stromal or 
epithelial cells to determine the molecular expression associated with 
decidualization, Kim et al. (2005) proposed that TGF β1 was the 
principal mediator for steroid action which leads to stromal 
decidualization. Polli et al. (1996) and Slater and Murphy (2000) 
indicated that TGF β1 is secreted apically from endometrial glands in 
the rat and is present in the uterine fluid at the time of implantation. 
This corresponds with the findings of the present study in which TGF β1 
was found to be apically localized in the luminal epithelial cells 
throughout the peri-implantation period.  Although some secretion has 
been found in the lumina of the glands in the control animals at 6.5 
days of pregnancy, it was not possible to confirm the nature of the 
secretion. However, these findings further support the investigation 
done by Slater and Murphy (2000). Lin et al. (2004) observed that 
during pre-implantation, both Smad 2 and Smad 4 were accumulated 
in the luminal and glandular epithelium, while in the peri-implantation 
period they were present in the luminal epithelial cells, subepithelial 
stromal compartment and the primary decidual zone. These findings 
by Lin et al. (2004) suggested that both Smads, being the intracellular 
transducers of the TGF β superfamily, are involved in tissue 
remodeling of the pregnant rat uterus. Together with previously 
mentioned observations regarding the presence of TGF β1 in the 
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epithelium and stroma (Godkin and Dore, 1998) and TGF β2 in the 
glandular epithelium, including the apical boarder and uterine lumen 
(Polli et al., 1996; Slater and Murphy, 2000), the current data showed 
expression of both TGF β1 and TGF β2 in the luminal epithelium and 
stroma.   
 
The results of the present study showed no differences in the 
expression of TGF β1 in the luminal and glandular epithelium between 
the control and the hyperstimulated animals. Differences between the 
control and hyperstimulated animals were however observed in the 
stroma of the hyperstimulated animals, which had regionalization in 
the expression of TGF β1 in all examined stages of pregnancy. This 
feature was absent in all relevant stages of pregnancy in the control 
groups. Thus it can be concluded that hyperstimulation had an 
influence on TGF β1 in the stromal compartment, which may contribute 
to a hostile environment for embryo implantation. 
 
Ovarian steroid hormones have a primary role in the regulation of 
temporal and cell-type specific proliferation and differentiation in the 
uterus. Also, the actions of oestrogen and progesterone are not direct, 
but are mediated through stimulatory or inhibitory effects on other 
molecules, such as TGF β’s (Murphy et al. 1987; Huet-Hudson et al. 
1990; Tamada et al. 1990; Tamada et al. 1991). In their study on the 
expression of different TGF β isoforms in the mouse uterus and the 
effects that ovarian steroids have on these growth factors during the 
peri-implantation period, Das et al. (1992) explained that different 
mechanisms are involved in the production of TGF β’s in this organ. In 
addition, Wakefield et al. (1990) proposed that regulation of 
production of TGF β  isoforms by oestrogen and progesterone is target 
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tissue specific. Similarly, in their study on the mammary gland 
concerning the activation of TGF-β by ovarian hormones, Ewan et al. 
(2002) showed that during the periods of proliferation i.e. puberty, 
oestrus and pregnancy, which are under control of ovarian hormones, 
TGF β1  activation decreased in some cells, consistent with preparation 
for proliferation.  In contradiction, other cells simultaneously increased 
TGF β1  immunoreactivity. Ewan et al. (2002) explained that this switch 
in the  synthesis indicates that ovarian hormones regulate TGF-
β1   activation, which in turn restricts the proliferative response to 
hormone signaling. The present study showed that the rat uterus is 
under the control of ovarian steroid hormones. Differences in the 
expression of the TGF βs between the control and hyperstimulated 
animals have been shown. In the light of the results obtained by Ewan 
et al. (2002), it is postulated that the regionalization in the expression 
of TGF β1   and TGF β2   i.e. the presence of two zones in the stroma of 
the hyperstimulated animals, occurred as a result of raised oestrogen 
and progesterone levels, which in turn influenced the response of the 
stromal cells. Consequently, the altered stromal environment 
contributed to the unfavorable state of the uterus for embryo 
implantation. 
 
Control animals showed TGF β1 expression at the antimesometrial pole, 
which was not observed in the hyperstimulated animals. Moulton 
(1994) showed that the TGF β1  and TGF β2  treatments induced 
apoptosis on cultured rat endometrial stromal cells as well as 
controlled apoptosis in the rat uterus during early pregnancy. Thus, 
the findings from the current study which showed localization of TGF 
β1  and TGF β2  at the antimesometrial side of the uterine lumen and 
around the implanting conceptus, suggests that both TGF β1  and TGF 
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β2  may play a role in the initiation of embryo implantation as well as in 
apoptosis. 
 
Apoptosis, programmed cell death, is said to be a crucial event in the 
physiology of endometrial stroma of normal cycling as well as pregnant 
uteri which enables the trophoblast cells to gain access to the maternal 
blood vessels (Moulton, 1994; Chatzaki, et al., 2003). Abrahamson 
and Zorn (1993) and Pampfer and Donnay (1999) observed some 
morphological characteristics of apoptosis in endometrial epithelial 
cells at embryo implantation sites in rodents. TGF β1 both inhibits cell 
proliferation and increases apoptosis of uterine epithelial cells in 
culture (Nawaz et al., 1987). TGF β2 secretion by endometrial cells 
controls stromal apoptosis during early pregnancy in vitro (Moulton, 
1994). Schooner et al. (2005) indicated that both TGF β1 and TGF β2 
were found in epithelial and stromal cells during early pregnancy in the 
rat. During late pregnancy, TGF β1 was immunolocalized mainly in the 
stroma, whereas TGF β2 was found mostly in the epithelial cells, and 
according to Shooner et al. (2005), at this particular time of the rat 
pregnancy, was involved in the regression of the decidua basalis.  
 
Comparisons between the control and hyperstimulated animals 
revealed a prominent difference in the expression of both the TGF β1 
and TGF β2 restricted to the antimesometrial side of the lumen as well 
as in the area surrounding the implanting conceptus. It is postulated 
that the hyperstimulation had a deleterious effect on the expression of 
both growth factors in this study, since the presence of neither TGF β1 
nor TGF β2 was observed at the antimesometrial side of the lumen in 
the hyperstimulated animals. Thus, it is believed that hyperstimulation 
provided an unfavorable environment for embryo implantation by 
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totally inhibiting the presence of TGF β1 and TGF β2 at the implantation 
sites. 
 
Furthermore, Chatzaki et al. (2003) suggested that endometrial 
stromal TGF β1 induced apoptosis of endometrial epithelial cells by 
having a major autocrine and/or paracrine pro-apoptotic effect on 
human endometrial cells in culture. The use of neutralizing antibodies 
for blockage of TGF β1, decreased apoptosis only by 22%, which 
suggested that endogenous TGF β1 does exert a pro-apoptotic effect on 
stromal cells, but only when its latent form is activated (Chatzaki et 
al., 2003). In addition, Moulton (1994) exposed stromal cells to steroid 
treatment for the experimental induction of decidualization, which 
caused, according to Lea et al., (1992), a switch from TGF β1 
expression to TGF β2. This suggests that TGF β2 may be more involved 
in inducing apoptosis of the rat decidua than the TGF β1 isoform. 
Indeed, results obtained from the present study, support findings 
made by Lea et al. (1992), Chatzaki et al. (2000) and Chatzaki et al. 
(2003) since, although TGF β1 was present around implantation 
chambers, the immunolocalization potency of the TGF β2 isoform, as 
well as its spatial and temporal expression was more pronounced than 
the TGF β1 isoform. 
 
Compared to the expression of TGF β2 in the control group, a gradual 
decline in the expression of TGF β2 in the luminal epithelium, stroma 
and glandular epithelium throughout the peri-implantation period was 
not observed in the hyperstimulated animals of the present study. It 
appears that hyperstimulation had an effect on the expression of TGF 
β2 in the stroma which resulted in regionalization of this growth factor.  
Moreover, hyperstimulation had a stimulatory effect on the expression 
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of TGF β2 in the glandular epithelium and myometrium. This resulted in 
the up-regulation of TGF β2 expression in these parts of the 
endometrium in the treated animals. 
 
According to Tamada et al. (1990), the luminal and glandular epithelial 
cells are primary sites of TGF β1 in mice uteri, while the 
immunolocalization of this peptide in the stroma, presents an 
accumulation of TGF β1 that has been synthesized and secreted from 
the epithelium.  Additionally, Tamada et al. (1990) showed that mRNA 
for both TGF β1 and TGF β2 is limited to the uterine luminal and 
glandular epithelium during the pre-implantation period in mice and to 
the decidua during the post-implantation period. Also, Chen et al. 
(1993) found mRNA for TGF-β1 present within the rat uterus during 
early and late pregnancy and restricted to the luminal and glandular 
epithelial cells. TGF β2   gene expression is similar to that of TGF β1, 
except that the former is also found in the uterine myometrium in 
mice (Das et al., 1992). Indeed, in the present study, the myometrium 
showed weak expression of TGF β1 and strong immunolocalization of 
TGF β2, throughout the peri-implantation period in both the control and 
hyperstimulated animal groups.  
 
The existence of yet another function of TGF βs is worthwhile 
mentioning in the context of our findings, by introducing an appealing 
immunological model which may explain the mechanisms that prevent 
the mother’s immune system from rejecting her concepti. Kauma et al. 
(1990) found that TGF β  and TGF β1  mRNA was localized at the 
human maternal-fetal interface, including the first trimester decidua, 
placenta and placental membranes. On the basis of their findings 
Kauma et al. (1990) presumed that TGF β s control the local maternal 
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immune response and prevent rejection of the fetus. Also, McLennan 
and Koishi (2004) compared the roles of both TGF β1 and TGF β2 as 
potential regulators of the immune system as well as factors that are 
involved in the continuation of pregnancy. In their findings McLennan 
and Koishi (2004) showed that maternal and fetal TGF β1 co-operate 
with each other to maintain the pregnancy within an immuno-
competent mother. Although TGF β2 was produced by the placenta 
(Das et al., 1992) and has a potential role in immune tolerance of the 
placenta (Clark et al., 1999), McLennan and Koishi (2004) believed 
that TGF β1 is a more suitable candidate for this role since it is 
ubiquitously present in fetal tissues (Heine et al., 1987).  
 
Additionally, Wira and Rossoll (2003) pointed out that increased levels 
of oestradiol during the reproductive cycle and after the treatment 
with exogenous hormones restrain the capability of stromal antigen- 
presenting cells (APC) to accomplish their role. Moreover, since the 
epithelium and stroma work together by producing factors that 
regulate their different functions, oestrogen inhibition of stromal cell 
antigen-presentation is mediated through its stimulatory effect on TGF 
β production by epithelial cells (Wira and Rossoll, 2003). In the present 
study oestrogen levels in the control animals showed a steady rise 
throughout the peri-implantation period. The weak presence of TGF β1 
immunolocalization in the luminal epithelial cells with apical 
concentration and strong within the stroma was also observed. 
However, TGF β2 expression showed a gradual decrease in all relevant 
areas of endometrium, from 4.5. 5.5 to 6.5 days of pregnancy, and 
absence of apical concentration in the luminal epithelium.  Additionally, 
TGF β1 was immunolocalized at the antimesometrial stromal side of the 
lumen, as well as in the trophoblast region, while the expression of 
98 
TGF β2 was not observed in the trophoblast region or any other part of 
the implanting blastocyst. Taken together findings of the present study 
support the work made by Wira and Rossoll (2003) and imply that the 
TGF β1 presents a more suitable candidate for the function in the 
uterine immunological response. It is believed that oestrogen could 
have had a stimulatory effect on TGF β1 production in the luminal 
epithelial cells, which then got released into the stroma to inhibit 
antigen presentation by uterine APC. The presence of TGF β1 at these 
sites of the maternal-fetal interface, support the above-mentioned 
presumptions made by Wira and Rossoll (2003), and offers an 
essential role of TGF β1 in the immune protection of the female 
reproductive tract and preservation of pregnancy. 
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5. CONCLUSION 
 
 
 
Despite the fact that hyperstimulation with exogenous gonadotropins 
is effective in multiple follicular development, there is a growing 
evidence of the deleterious effects of this procedure on the uterine 
endometrium. The results of the present investigation suggest that 
exogenous administration of FSH and hCG, which has been routinely 
used in IVF and ET programmes, interferes with the regular expression 
of TGF β1 and TGF β2, whose actions are necessary for normal 
endometrial development in preparation for embryo implantation and 
successful pregnancy. This is yet another important consideration that 
needs to be addressed when assessing the low pregnancy rate in 
assisted reproductive programmes. 
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APPENDIX 
 
 
 
1.  Shorr’s staining technique (Drury and Wallington, 1980) 
Ethyl alcohol (50 per cent)                 100 cm3 
Biebrich scarler (water soluble)             0.5 g 
Orange G                                                0.25 g 
Fast green FCF                                       0.075 g 
Phosphotungstic acid                              0.5 g 
Phosphomolybdic acid                            0.5 g 
Glacial acetic acid                           1 cm3 
 
 
Method 
 
1.  Mix all ingredients by shaking 
2.  Filter  
3.  Stain smears for 1 minute 
4.  Rinse in 70% alcohol for 2x1 minute 
5.  Dehydrate through graded alcohols (95% and 100%) 
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2.  Assessment of vaginal smears (Kent and Smith 1945) 
 
 
 
 
 
Oestrus  Metoestrus 
 
 
 
Abundance of cornified polygonal cells 
 
Abundance of elongated cornified cells. Some 
nucleated cuboidal cells. Occasional 
leucocytes 
 
 
Early-dioestrus  Mid-dioestrus 
 
 
 
Numerous nucleated cuboidal cells. 
Some cornified polygonal cells. 
Abundance of leucocytes 
 
 
 
Numerous nucleated cuboidal cells. 
Occasional elongated  polygonal cornified 
cells. Some leucocytes 
 
 
Late-dioestrus  Proestrus 
 
 
 
Elongated to polygonal cornified cells 
fairly numerous. Some nucleated 
cuboidal cells. Occasional leucocytes 
 
 
 
Polygonal cornified cells numerous. Some 
nucleated cuboidal cells. Some nucleated 
cuboidal cells. Very few leucocytes 
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3. 10% Neutral buffered formalin   
Formalin    100 ml 
Sodium dihydrogen phosphate                                     3.5 g
Di-sodium hydrogen phosphate                                    6.5 g
Distilled water                                                           900 ml
 
 
 
 
4. Silane coated slides (Mutter, 1988)  
1. Soak slides in 10% Contrad or Super 10 overnight 
2. Rinse in hot running water – minimum – 2 hours 
3. Dry in oven at 60°C 
4. Dip in Acetone (optional) 
5. Dip in 2% Silane in Acetone for 30 minutes (6ml Silane + 
294ml Acetone) 
6. Wash in two changes of acetone 1-2 dips 
7. Wash briefly in distilled water 
8. Dry in 42°C incubator overnight 
 
 
 
5. Haematoxylin and eosin staining technique (Bancroft and 
Gamble, 2002) 
  
Acid haematoxylin (modified Mayer’s)  
Haematoxylin 1 g 
Sodium Iodate                                                    0.2 g 
Potassium Alum                                                   50 g 
Citric Acid                                                            1 g 
Chloral Hydrate                                                    50 g 
Distilled water                                                 1 l 
Allow haematohylin, alum and sodium iodate to dissolve overnight. 
Add chloral hydrate and citric acid and bring to the boil. Continue 
boiling for 5 minutes after which the solution is cooled and ready for 
use. 
 
Stock Eosin  
Eosin 8 g 
Erythrosin 2 g 
Distilled water                                                  1 l 
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Eosin working solution  
Stock Eosin                                                          250 ml 
Distilled water                                                      750 ml 
Calcium Chloride                                                    20 g 
  
  
Method 
1. Dewax  and hydrate sections 
 
2. Stain in haematoxylin for 6-20 minutes depending on 
the strength of the stain and the fixative used 
3. Wash well in running tap water. The sections may be 
examined microscopucally at this stage to confirm a 
sufficient degree of staining. If insufficient, return to  
the stain 
4. Remove the excess stain by differentiating in 1% 
hydrochloric acid in 70% alcohol (usually a few quick 
dips). The blue staining of the haematoxylin is changed 
to red by the action of the acid.  
5. Regain the blue colour by washing in alkaline running 
tap water. The stain should be again checked 
microscopically until correct degree of staining is 
obtained. 
 
 
 
 
 
6. Citrate Buffer pH 6 
Solution A 
 
0.1 M Citric acid 
10.5 g Citric acid in 500ml 
distilled water 
Solution B 
 
 
0.1 M Sodium Citrate 
29.4g Sodium Citrate in 1000ml 
distilled water 
Mix 9ml of solution A and 41 ml of solution B and make  up to 500 ml 
at distilled water 
Boil for 2x 5 minutes at high power. 
Allow slides to cool for 20 minutes 
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7. Tris buffered saline 7.6 pH 
 
Tris base                                                   12.12 g 
NaCl   17.54 g 
 
Destilled water                                                2l 
pH to 7.6 
 
 
 
 
 
8. D.A.B. 
Weight 1mg (0.001g) D.A.B. into new bijou bottle 
At start of second day of run put measuring cylinder containing 29ml 
distilled water into fridge at 4C 
Just before use add 2ml Tris HCl pH 7.6 to D.A.B. in bijou bottle 
Then add 1ml 30% Perhydrol to the now cold distilled water to make 
a 1% solution and mix well. 
Add 20ul of the 1% perhydrol to the D.A.B. solution, mix on whirlimix 
Filter before use 
Pippete onto section timing each individually for 5 minutes 
 
 
 
 
 
 
 
 
 
 
